Other soft tissue disorders, not elsewhere classified

M13_SOFTTISSUEOTH

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M79 Cause of death: ICD-10 — M79 2 out of 7 registries used, show all original rules.	70697
4. Check minimum number of events None	70697
5. Include endpoints M13_RHEUMATISM M13_MYALGIA M13_NEURALGIA M13_PANNICULITISNAS M13_FATPADHYPERTROPHY M13_FOREIGNBODY M13_LIMBPAIN M13_FIBROMYALGIA M13_SOFTTISSUENAS	71810
6. Filter based on genotype QC (FinnGen only)	69131

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M70-M79
Name in latin: Aliae morbositates textus mollis non alibi classificatae

NAME	M13_SOFTTISSUEOTH
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_RHEUMATISM\|M13_MYALGIA\|M13_NEURALGIA\|M13_PANNICULITISNAS\|M13_FATPADHYPERTROPHY\|M13_FOREIGNBODY\|M13_LIMBPAIN\|M13_FIBROMYALGIA\|M13_SOFTTISSUENAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M79
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M79
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other soft tissue disorders, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	461182	282951	175757
Only index persons	428764	267123	161641
Unadjusted period prevalence (%)
Whole population	6.86	8.10	4.91
Only index persons	8.44	9.82	6.17
Median age at first event (years)
Whole population	51.88	52.52	51.00
Only index persons	52.01	52.41	51.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69131	45934	23197
Unadjusted period prevalence (%)	14.39	16.29	10.63
Median age at first event (years)	55.70	53.07	60.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60373: Matched controls
353752

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A99

ICPC

Disease/condition unspecnature/site

1.9

323.0

4634

14552

M76.0

ICD-10 Finland

Gluteal tendinitis

4.7

322.6

925

1169

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

322.5

6011

20549

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

321.1

9453

36602

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

320.7

3753

10941

R03AC03

ATC

terbutaline; inhalant

1.7

320.5

6923

24707

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

320.2

1772

3618

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.7

319.9

1238

1999

R55

ICD-10 Finland

Syncope and collapse

1.8

319.5

5383

17829

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.1

319.3

1604

3089

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

319.0

2680

6796

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

317.5

38019

193267

H57.1

ICD-10 Finland

Ocular pain

2.7

316.3

2078

4667

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.5

315.4

2289

5411

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

315.3

3488

9946

A03

ICPC

Fever

1.6

315.0

9455

36766

D02

ICPC

Abdominal pain epigastric

2.2

314.9

3199

8812

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

3.6

314.5

1267

2106

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

314.5

10334

41055

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

6.1

311.7

690

671

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

8.8

311.5

519

348

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

311.4

3350

9445

B01AF02

ATC

apixaban; oral

1.8

310.1

5373

17946

ZXA05

NOMESCO Finland

Left side

2.0

307.7

12788

41587

M01AE01

ATC

ibuprofen; systemic, rectal

2.0

307.7

52749

273221

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

32964

152737

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

307.7

18192

59710

SPAT1301

SPAT

No procedures

1.7

307.7

17061

67629

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

307.7

14488

51242

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

24821

98173

A28

ICPC

Limited function/disability NOS

2.0

307.7

8216

25703

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.7

307.7

829

856

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

12.0

307.7

686

338

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.6

307.7

7826

11114

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.5

307.7

1656

2827

M19.8

ICD-10 Finland

Other specified arthrosis

3.2

307.7

1789

3310

WX320

NOMESCO Finland

Spinalanesthesy

2.0

307.7

12932

43058

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

307.7

19383

73652

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

9976

35187

J01FA10

ATC

azithromycin; systemic

1.6

307.7

32780

150618

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

307.7

3284

7967

N06AA10

ATC

nortriptyline; systemic

4.9

307.7

1325

1626

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.7

307.7

1394

2274

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

4.0

307.7

2380

3612

D11

ICPC

Diarrhoea

1.9

307.7

6840

22043

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.2

307.7

9705

19981

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

11568

38576

XF402

NOMESCO Finland

ECG with work load test

2.1

307.7

4947

14536

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

307.7

2815

7227

N02AJ13

ATC

tramadol and paracetamol; systemic

3.8

307.7

1189

1846

L90

ICPC

Osteoarthrosis of knee

2.4

307.7

2903

7278

R51.80

ICD-10 Finland

Headache

2.9

307.7

11534

26431

SPAT1211

SPAT

Application of soft bandage

2.0

307.7

4573

13607

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

307.7

10696

42422

N05CF02

ATC

zolpidem; oral

1.8

307.7

9059

31471

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

307.7

6177

19595

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

18415

69051

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

307.7

2492

5799

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

25060

79747

A04

ICPC

Weakness/tiredness general

1.9

307.7

8363

28171

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

307.7

3311

8882

T90

ICPC

Diabetes non-insulin dependent

1.7

307.7

10977

41592

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

3.0

307.7

2069

4125

R74

ICPC

Upper respiratory infection acute

1.6

307.7

18712

76869

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

307.7

4709

14765

E66.8

ICD-10 Finland

Other obesity

2.4

307.7

3112

7735

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

307.7

5147

15916

C10AA07

ATC

rosuvastatin; oral

1.6

307.7

14688

58217

L14

ICPC

Leg/thigh symptom/complaint

2.9

307.7

4935

10501

M77.0

ICD-10 Finland

Medial epicondylitis

4.0

307.7

1330

1988

M79.3

ICD-10 Finland

Panniculitis, unspecified

91.9

307.7

343

A98

ICPC

Health maint/preventive medicine

2.2

307.7

57359

316871

M54.4

ICD-10 Finland

Lumbago with sciatica

3.3

307.7

12786

26778

M15

ICD-10 Finland

Polyarthrosis

2.7

307.7

2144

4804

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

307.7

15017

58305

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

307.7

3364

8939

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.7

307.7

1305

2106

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.9

307.7

1333

2027

R01AD58

ATC

fluticasone, combinations; nasal

1.6

307.7

13308

52871

L04

ICPC

Chest symptom/complaint

2.3

307.7

3261

8563

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

307.7

2371

5566

L28

ICPC

Limited function/disability (L)

2.7

307.7

10482

25984

R12

ICD-10 Finland

Heartburn

2.0

307.7

4150

12333

N03AE01

ATC

clonazepam; systemic

2.9

307.7

3293

6906

R01AD09

ATC

mometasone; nasal

1.7

307.7

25757

108412

W19

ICD-10 Finland

Unspecified fall

2.1

307.7

5330

15608

G47.3

ICD-10 Finland

Sleep apnoea

2.0

307.7

12630

40527

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

307.7

5081

15285

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.9

307.7

2515

2224

NBG10

NOMESCO Finland

Acromioplastia

18.7

307.7

1082

345

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

49.2

307.7

1298

158

K07.60

ICD-10 Finland

Snapping jaw

2.9

307.7

3327

6971

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

307.7

11233

30156

J01CA04

ATC

amoxicillin; systemic

1.7

307.7

47747

243439

C09CA06

ATC

candesartan; oral

1.6

307.7

11766

45329

N02BF02

ATC

pregabalin; oral

4.2

307.7

4237

6199

R51

ICD-10 Finland

Headache

2.2

307.7

3163

8565

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

4.7

307.7

2099

2699

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

307.7

7394

26249

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

15341

57035

R20.2

ICD-10 Finland

Paraesthesia of skin

2.9

307.7

4583

9785

M13.9

ICD-10 Finland

Arthritis, unspecified

2.8

307.7

4314

9388

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.1

307.7

5355

15430

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

307.7

4276

10986

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

307.7

4894

10147

N06AX11

ATC

mirtazapine; oral

2.0

307.7

20636

71640

A46

ICD-10 Finland

Erysipelas

2.2

307.7

7898

22891

P06

ICPC

Sleep disturbance

1.9

307.7

6395

21137

C01DA14

ATC

isosorbide mononitrate; oral

1.8

307.7

6554

22840

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

4.1

307.7

1116

1629

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

21782

92929

SPAT1312

SPAT

General health counselling

1.5

307.7

17062

74327

C08CA01

ATC

amlodipine; oral

1.6

307.7

18110

73572

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

307.7

4214

12735

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

307.7

6552

19829

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

7.7

307.7

1098

854

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

307.7

19767

87952

M01AX17

ATC

nimesulide; oral

2.2

307.7

12348

37258

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

307.7

1717

3239

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

307.7

4613

9995

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.2

307.7

3044

5762

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.2

307.7

2716

5112

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

307.7

4153

8979

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.5

307.7

1450

1933

H02AB04

ATC

methylprednisolone; systemic

2.1

307.7

7677

23225

L02

ICPC

Back symptom/complaint

2.3

307.7

6056

16194

M79.0

ICD-10 Finland

Rheumatism, unspecified

66.2

307.7

4683

449

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

17095

70640

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.1

307.7

10004

13200

UKC02

NOMESCO Finland

Cystoscopy

1.9

307.7

7777

25577

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

6.6

307.7

898

812

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.4

307.7

1704

2335

R03BA01

ATC

beclometasone; inhalant

1.8

307.7

6847

23862

R21

ICPC

Throat symptom/complaint

1.6

307.7

12430

49178

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.7

307.7

4083

6803

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

307.7

11398

40230

M79.7

ICD-10 Finland

Fibromyalgia

21.1

307.7

4532

1353

N06AA09

ATC

amitriptyline; systemic

4.0

307.7

6478

10417

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.7

307.7

3244

7271

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

307.7

15046

63238

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.1

307.7

1723

2489

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

11.5

307.7

629

323

C10AA01

ATC

simvastatin; oral

1.5

307.7

18590

79485

N03AX16

ATC

[U] pregabalin

4.3

307.7

18495

33224

N06AX16

ATC

venlafaxine; oral

2.4

307.7

9409

24882

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

307.7

4745

14509

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

307.7

3112

7993

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.3

307.7

3941

7278

M79.6

ICD-10 Finland

Pain in limb

21.4

307.7

50106

65704

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.3

307.7

1577

2180

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.2

307.7

15440

26898

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

9414

32223

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

307.7

4011

11388

M77.4

ICD-10 Finland

Metatarsalgia

3.4

307.7

3292

5879

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

25410

113769

A08

ICPC

Swelling

2.7

307.7

2550

5653

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.9

307.7

8090

18100

EBA00

NOMESCO Finland

Extraction of tooth

1.4

307.7

19131

85982

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.3

307.7

5635

15462

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.5

307.7

5236

13090

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

307.7

4336

10972

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.2

307.7

3980

5893

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

307.7

12582

49492

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.1

307.7

7459

15491

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

307.7

17783

48911

X58

ICD-10 Finland

Exposure to other specified factors

2.3

307.7

8661

24371

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

307.7

13520

41601

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

307.7

13984

56471

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

10.5

307.7

1197

680

M66.0

ICD-10 Finland

Rupture of popliteal cyst

13.0

307.7

597

271

R4120

NOMESCO Finland

Occupational therapy

2.7

307.7

3614

8181

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

307.7

3602

10278

L09

ICPC

Arm symptom/complaint

2.7

307.7

2672

5928

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.6

307.7

6363

11291

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.5

307.7

7136

18005

L08

ICPC

Shoulder symptom/complaint

2.6

307.7

12754

32845

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

307.7

2699

5555

R03BB04

ATC

tiotropium bromide; inhalant

2.0

307.7

4651

14440

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

307.7

5324

14995

D06

ICPC

Abdominal pain localized other

2.2

307.7

5004

13831

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.1

307.7

2285

3373

SPAT1263

SPAT

Sampling

1.7

307.7

24027

99726

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

307.7

3394

8054

R13

ICD-10 Finland

Dysphagia

2.4

307.7

3417

8568

C07AA05

ATC

propranolol; systemic

1.7

307.7

11232

41393

R02

ICPC

Shortness of breath/dyspnoea

2.4

307.7

7687

20561

L04AX03

ATC

methotrexate; systemic

2.3

307.7

5157

14033

B01AC04

ATC

clopidogrel; oral

1.9

307.7

7497

24167

H01

ICPC

Ear pain/earache

1.9

307.7

6521

21646

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.8

307.7

2525

5399

M01AC06

ATC

meloxicam; systemic, rectal

2.2

307.7

20167

66363

J45

ICD-10 Finland

Asthma

1.9

307.7

5360

16959

SPAT1153

SPAT

Removal of sutures

1.9

307.7

16607

58866

R4110

NOMESCO Finland

Physiotherapy

2.0

307.7

15651

52918

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.7

307.7

1122

1175

R35

ICD-10 Finland

Polyuria

2.3

307.7

3286

8752

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

307.7

13627

53451

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

22210

94944

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

307.7

10362

35998

J01DA09

ATC

[U] cefadroxil

1.5

307.7

13526

55981

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

307.7

6342

15776

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

20234

83059

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.6

307.7

1290

1680

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

307.7

2650

5579

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

8653

28018

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

32411

138450

R5110, ,

SPAT

2.4

307.7

3092

7831

N06AB04

ATC

citalopram; systemic

1.9

307.7

11559

39883

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

307.7

1932

3658

R51.81

ICD-10 Finland

Facial pain NOS

3.6

307.7

1344

2231

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

307.7

5448

16873

SPAT1254

SPAT

Administration of medicine

1.8

307.7

8146

27722

R52.2

ICD-10 Finland

Other chronic pain

6.1

307.7

2909

2933

L20

ICPC

Joint symptom/complaint NOS

2.8

307.7

2006

4261

R03BA02

ATC

budesonide; inhalant

1.7

307.7

9223

33852

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

27726

114488

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

307.7

5522

14170

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

11223

32475

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

307.7

11803

46533

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

307.7

3563

8452

WZC30

NOMESCO Finland

Teaching

1.7

307.7

7596

26963

N03AX12

ATC

[U] gabapentin; oral

4.8

307.7

13576

20014

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

8.0

307.7

931

689

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

307.7

4130

11375

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

307.7

5623

18007

N05CF01

ATC

zopiclone; oral

1.8

307.7

17473

64118

L03

ICPC

Low back symptom/complaint

2.4

307.7

17944

52859

J01FF01

ATC

clindamycin; systemic

2.0

307.7

15814

52994

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

307.7

10924

42923

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

8.2

307.7

618

443

H02AB06

ATC

prednisolone; systemic

2.2

307.7

29259

104828

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.1

307.7

1197

1726

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

307.7

30224

132611

M01AE02

ATC

naproxen; oral, rectal

1.9

307.7

33780

139670

J01FA09

ATC

clarithromycin; systemic

1.7

307.7

16784

66139

B01AA03

ATC

warfarin; systemic

1.7

307.7

8741

31572

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

16520

47840

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

307.7

19986

81189

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

14.4

307.7

906

375

KMAK, ,

NOMESCO Finland

1.5

307.7

28112

131520

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

307.7

12291

46925

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

307.7

29510

129856

R07.3

ICD-10 Finland

Other chest pain

2.7

307.7

6166

14419

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.5

307.7

1518

2605

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

15090

49079

M01AB05

ATC

diclofenac; systemic, rectal

2.3

307.7

39461

161311

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

307.7

10443

39606

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

307.7

11332

44656

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

21780

88270

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

9.3

307.7

937

597

N06AB10

ATC

escitalopram; oral

1.6

307.7

11513

44830

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.4

307.7

2583

4657

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

307.7

17661

65843

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

307.7

5002

13598

Z3226

NOMESCO Finland

Physiotherapist

2.1

307.7

10316

31150

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

33521

134531

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

307.7

6045

18918

M01AX05

ATC

glucosamine; oral

2.1

307.7

8786

26231

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

307.7

8757

31800

R11

ICD-10 Finland

Nausea and vomiting

2.1

307.7

4890

14023

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

307.7

15611

46498

J01EA01

ATC

trimethoprim; systemic

1.6

307.7

13459

52514

R50.9

ICD-10 Finland

Fever, unspecified

1.8

307.7

8246

28244

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

307.7

4850

14441

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.0

307.7

1872

3681

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

307.7

12248

48541

L16

ICPC

Ankle symptom/complaint

2.4

307.7

6929

17988

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

24358

83440

L86

ICPC

Back syndrome with radiating pain

3.3

307.7

3665

6896

M89.0

ICD-10 Finland

Algoneurodystrophy

12.1

307.7

702

344

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

307.7

12126

33903

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.4

307.7

2885

3279

J20

ICD-10 Finland

Acute bronchitis

1.9

307.7

5270

16603

L12

ICPC

Hand/finger symptom/complaint

2.4

307.7

10112

26954

S18

ICPC

Laceration/cut

2.1

307.7

26483

95745

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.5

307.7

2101

3638

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

21.4

307.7

609

168

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

307.7

3748

9205

Z2221

NOMESCO Finland

Medical doctor

1.6

307.7

14514

59742

A02BC02

ATC

pantoprazole; systemic

2.7

307.7

42161

163764

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.6

307.7

984

1265

N01

ICPC

Headache

2.0

307.7

6911

21749

N06AB03

ATC

fluoxetine; oral

1.8

307.7

6351

21280

R60.0

ICD-10 Finland

Localized oedema

2.8

307.7

7576

16980

M70.6

ICD-10 Finland

Trochanteric bursitis

3.9

307.7

7946

13229

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

307.7

12029

40821

K08.80

ICD-10 Finland

Toothache NOS

2.0

307.7

4804

14691

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

307.7

3578

9916

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

307.7

5651

13531

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.1

307.7

4240

8461

A06AD11

ATC

lactulose; oral

1.9

307.7

7203

23729

M77.1

ICD-10 Finland

Lateral epicondylitis

3.1

307.7

4513

8955

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

307.7

5993

16795

S70.0

ICD-10 Finland

Contusion of hip

2.8

307.7

1955

4186

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

15561

48257

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.6

307.7

28757

91161

SPAT1229

SPAT

Assessment of need for aid

2.4

307.7

3879

9658

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.6

307.7

6303

15147

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

307.7

5266

14307

R4110, ,

SPAT

2.6

307.7

4638

11002

UJF32

NOMESCO Finland

Coloscopy

2.1

307.7

14496

46508

R52.1

ICD-10 Finland

Chronic intractable pain

8.2

307.7

653

471

M01AB55

ATC

diclofenac, combinations; oral

2.8

307.7

3241

7117

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

307.7

8732

31309

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.5

307.7

2142

3643

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

22604

95758

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

13551

40167

A11

ICPC

Chest pain NOS

2.4

307.7

4282

10765

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.7

307.7

1858

2993

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

307.7

7533

24969

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.2

307.7

1892

2167

N02AA05

ATC

oxycodone; systemic

2.4

307.7

9893

26497

M01AX01

ATC

nabumetone; oral

2.9

307.7

1953

4095

M54.5

ICD-10 Finland

Low back pain

2.8

307.7

25085

71506

M54.8

ICD-10 Finland

Other dorsalgia

2.9

307.7

2620

5457

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

307.7

6813

19900

K30

ICD-10 Finland

Functional dyspepsia

2.2

307.7

6325

17509

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

23092

88101

D01

ICPC

Abdominal pain/cramps general

2.1

307.7

7036

21133

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

307.7

2641

5691

M48.0

ICD-10 Finland

Spinal stenosis

3.5

307.7

7429

13508

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.1

307.7

2338

4525

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

307.7

4190

10810

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.1

307.7

3972

4850

ZXA00

NOMESCO Finland

Right side

2.1

307.7

13828

44264

N05BA04

ATC

oxazepam; oral

1.9

307.7

14944

53405

71798

ICD-8 Finland

Other nonarticular rheumatism, Other muscular rheumatism, fibrositis and myalgia

+∞

307.7

564

ZXA10

NOMESCO Finland

Bilateral

1.7

307.7

9068

32811

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.5

307.7

1854

3201

J01CA08

ATC

pivmecillinam; oral

1.5

307.7

20633

92125

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

26557

121258

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

307.7

2745

6883

N17

ICPC

Vertigo/dizziness

2.0

307.7

6335

19182

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

307.7

14935

49455

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

307.7

7516

17427

M10.9

ICD-10 Finland

Gout, unspecified

2.3

307.7

3207

8368

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

307.7

3962

9789

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

307.7

2225

4422

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

307.7

17972

76121

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

4.1

307.7

2058

3009

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.9

307.7

5797

12317

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

38423

187263

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

13.1

307.7

2514

1170

SPAT1216

SPAT

Assessment of functional ability

2.0

307.7

7787

24291

J01MA02

ATC

ciprofloxacin; systemic

1.8

307.7

21290

82949

C07AB07

ATC

bisoprolol; oral

1.8

307.7

25490

100231

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

307.7

7965

24925

M67.4

ICD-10 Finland

Ganglion

4.0

307.7

3088

4654

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

6.7

307.7

1035

918

Z50.1

ICD-10 Finland

Other physical therapy

2.8

307.7

2666

5774

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

307.7

3686

9729

M02AA10

ATC

ketoprofen; topical

2.1

307.7

8182

24276

SPAT1262

SPAT

Handing over of treatment supplies

1.7

307.7

8250

30570

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

8787

30203

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

307.7

6165

17674

J02AC01

ATC

fluconazole; systemic

1.7

307.7

21900

87243

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.0

307.7

2350

3532

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

17202

72001

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

307.7

18855

83885

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

7797

25962

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

28.1

307.7

799

169

M54

ICD-10 Finland

Dorsalgia

2.0

307.7

7108

21980

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

307.7

14571

46591

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

11283

33107

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

4.5

307.7

1611

2163

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

307.7

5945

17651

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.3

307.7

9787

15284

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

17710

52476

R96

ICPC

Asthma

2.3

307.7

5182

13888

N05AH04

ATC

quetiapine; oral

1.9

307.7

10667

35798

S21

ICPC

Skin texture symptom/complaint

1.9

307.7

7350

24565

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

307.7

14128

55468

H02AB07

ATC

prednisone; oral

1.9

307.7

6986

22470

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

307.7

8943

32112

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

307.7

4671

14369

M54.2

ICD-10 Finland

Cervicalgia

3.4

307.7

5218

9677

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

307.7

5311

17207

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

307.7

3524

9263

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.1

307.7

4227

8295

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.9

307.7

1910

3910

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

307.7

10864

39738

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

307.7

14846

40362

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.9

307.7

2003

3116

M79.5

ICD-10 Finland

Residual foreign body in soft tissue

10.8

307.7

2359

1333

L05

ICPC

Flank/axilla symptom/complaint

2.4

307.7

3144

7862

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

307.7

30064

131019

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

307.7

4439

11030

ACC51

NOMESCO Finland

Release of median nerve

3.0

307.7

3996

8043

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

307.7

3816

7128

A02BC01

ATC

omeprazole; systemic

2.0

307.7

15490

52705

H03AA01

ATC

levothyroxine sodium; systemic

1.6

307.7

11247

44613

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

10974

40616

M75.2

ICD-10 Finland

Bicipital tendinitis

4.2

307.7

1107

1557

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

307.7

10681

32963

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

307.7

4116

10654

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

307.7

10299

37406

M01AB08

ATC

etodolac; oral

2.2

307.7

3213

8712

M54.3

ICD-10 Finland

Sciatica

3.2

307.7

3493

6689

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.7

307.7

4149

9396

S80.0

ICD-10 Finland

Contusion of knee

2.4

307.7

4340

10918

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.4

307.7

3332

8568

A29

ICPC

General symptom/complaint other

1.9

307.7

6332

20781

S97

ICPC

Chronic ulcer skin

2.6

307.7

3030

7105

M35.7

ICD-10 Finland

Hypermobility syndrome

6.7

307.7

1141

1009

S29

ICPC

Skin symptom/complaint other

1.8

307.7

10184

35196

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

307.7

4009

11070

SPAT1097

SPAT

Recording of ECG

1.8

307.7

6736

23146

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

307.7

4912

15092

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

307.7

3859

9193

N05BA01

ATC

diazepam; systemic, rectal

2.0

307.7

6990

21396

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

307.7

15716

52053

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

307.7

4967

12707

R05

ICPC

Cough

1.9

307.7

13871

47375

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.2

307.7

5426

14892

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

307.7

42429

197094

M79.8

ICD-10 Finland

Other specified soft tissue disorders

13.6

307.7

492

213

ZXD05

NOMESCO Finland

Urgent procedure

1.6

307.7

16505

68006

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

307.7

6272

19864

Z00.0

ICD-10 Finland

General medical examination

1.7

307.7

10098

38046

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

307.7

21026

92715

A02BC04

ATC

rabeprazole; oral

2.2

307.7

4420

12475

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.7

307.7

1109

860

D07AC01

ATC

betamethasone; topical

1.6

307.7

18851

78987

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.9

307.7

5594

9050

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

307.7

42677

201226

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

307.7

10244

36889

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

307.7

17024

61524

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

307.7

6590

22812

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.4

307.7

3177

8010

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

307.7

5530

11759

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

307.7

5502

16979

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

307.7

8877

27511

M54.1

ICD-10 Finland

Radiculopathy

4.1

307.7

2478

3697

M02AA07

ATC

piroxicam; topical

2.1

307.7

19609

65744

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.2

307.7

8450

17078

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

34114

158786

C03CA01

ATC

furosemide; systemic

1.9

307.7

15021

52676

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

17.3

307.7

3132

1116

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

307.7

4104

8090

ZXE00

NOMESCO Finland

One hour or less

1.7

307.7

21294

87710

M03BX02

ATC

tizanidine; oral

2.4

307.7

38372

149912

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

307.7

1794

3426

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.8

307.7

2813

4451

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.6

307.7

2569

5970

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

307.7

3101

7131

R05

ICD-10 Finland

Cough

1.9

307.7

11553

40047

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

307.7

4233

12594

B01AB05

ATC

enoxaparin; parenteral

2.1

307.7

18126

59518

J01FA06

ATC

roxithromycin; oral

1.7

307.7

21609

85696

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

14812

60125

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

28.3

307.7

518

108

M79.1

ICD-10 Finland

Myalgia

6.1

307.7

15532

18892

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

307.7

5723

10430

J01AA02

ATC

doxycycline; systemic

2.1

307.7

44786

204153

C10AX09

ATC

ezetimibe; oral

1.9

307.7

6953

22853

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

307.7

5431

14011

R06AX27

ATC

desloratadine; oral

1.5

307.7

15519

64847

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

307.7

4087

11532

L15

ICPC

Knee symptom/complaint

2.3

307.7

14109

41408

WX200

NOMESCO Finland

Interscalenous plexus blockade

5.4

307.7

949

1041

N06AX21

ATC

duloxetine; oral

4.4

307.7

9798

14957

R00.2

ICD-10 Finland

Palpitations

2.2

307.7

4250

11899

L29

ICPC

Musculoskeletal sympt/complt other

2.5

307.7

4870

11948

R03BA08

ATC

ciclesonide; inhalant

2.0

307.7

4299

13102

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

16842

68727

N02AJ06

ATC

codeine and paracetamol; systemic

2.7

307.7

28286

86906

M01AH01

ATC

celecoxib; oral

2.6

307.7

10155

25951

A02BA02

ATC

ranitidine; systemic

2.0

307.7

9913

30967

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.2

307.7

5648

8517

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

307.7

27187

95055

SPAT1260

SPAT

Consultation of another employee

1.9

307.7

9650

32878

R09

ICPC

Sinus symptom/complaint

2.0

307.7

4374

13230

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

307.7

9063

24698

G50.1

ICD-10 Finland

Atypical facial pain

4.6

307.7

1099

1410

N02AX02

ATC

tramadol; systemic, rectal

3.2

307.7

29754

81758

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

307.7

7527

23343

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

307.7

3104

6350

M70.7

ICD-10 Finland

Other bursitis of hip

4.1

307.7

1182

1696

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

11055

37385

R52.0

ICD-10 Finland

Acute pain

3.1

307.7

1972

3873

G44.2

ICD-10 Finland

Tension-type headache

2.8

307.7

9310

21982

J01DB01

ATC

cefalexin; oral

2.4

307.7

50256

238415

N04BC05

ATC

pramipexole; oral

2.6

307.7

3937

9132

N02BF01

ATC

gabapentin; oral

4.5

307.7

6056

8547

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

307.7

8238

26586

E0000UV, ,

ATC

1.5

307.7

22700

99931

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

7563

23789

R06AE07

ATC

cetirizine; oral

1.6

307.7

24828

106494

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

307.7

6430

20506

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

307.7

12106

48440

G54.0

ICD-10 Finland

Brachial plexus disorders

5.8

307.7

1868

1944

M43.1

ICD-10 Finland

Spondylolisthesis

3.0

307.7

1924

3847

L11

ICPC

Wrist symptom/complaint

2.3

307.7

5031

13504

XA402

NOMESCO Finland

ENMG

4.8

307.7

1494

1845

WX402

NOMESCO Finland

General anaesthesia

1.6

307.7

11029

42471

M01AH02

ATC

rofecoxib; oral

2.5

307.7

6541

16315

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

307.7

7167

23753

L01

ICPC

Neck symptom/complaint

2.4

307.7

9694

26276

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

307.7

3829

10348

S22.3

ICD-10 Finland

Fracture of rib

2.4

307.7

3698

9319

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.8

307.7

1505

833

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

307.7

5211

13968

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

307.7

422

M25.5

ICD-10 Finland

Pain in joint

3.1

307.7

22689

56949

L13

ICPC

Hip symptom/complaint

2.6

307.7

10338

25917

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

307.7

17157

50716

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

8374

27053

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

307.7

8263

27149

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

21967

95963

C10AA05

ATC

atorvastatin; oral

1.6

307.7

19616

79901

N02BE01

ATC

paracetamol; systemic, rectal

3.9

307.7

54893

255472

M65.3

ICD-10 Finland

Trigger finger

6.2

307.7

2027

1982

M76.6

ICD-10 Finland

Achilles tendinitis

3.4

307.7

2316

4103

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.4

307.7

1550

2734

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

307.7

6014

17473

R52.9

ICD-10 Finland

Pain, unspecified

3.2

307.7

6926

13606

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

5.7

307.7

1059

1105

R01AD08

ATC

fluticasone; nasal

1.6

307.7

15294

60962

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

307.7

7465

21736

A02BC03

ATC

lansoprazole; oral

2.1

307.7

16100

51534

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

307.7

6685

22695

J01DA01

ATC

[U] cefalexin

1.7

307.7

34902

157886

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.6

307.7

11580

29457

M75.8

ICD-10 Finland

Other shoulder lesions

3.5

307.7

1955

3346

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

307.7

3338

9212

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.4

307.7

5609

14597

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.5

307.7

1384

1841

L17

ICPC

Foot/toe symptom/complaint

2.6

307.7

18858

52934

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.6

307.7

1227

1585

B01AF01

ATC

rivaroxaban; oral

2.1

307.7

5842

17302

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

307.7

20425

72631

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

307.7

5183

14452

S06.0

ICD-10 Finland

Concussion

2.2

307.7

6384

18321

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

10.0

307.7

3883

2415

L18

ICPC

Muscle pain

2.7

307.7

2287

5113

N03AX09

ATC

lamotrigine; oral

2.8

307.7

3218

7051

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

307.7

6135

20588

G04BD12

ATC

mirabegron; oral

2.1

307.7

5296

15808

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

31265

142047

A01

ICPC

Pain general/multiple sites

3.6

307.7

6537

11551

U02

ICPC

Urinary frequency/urgency

1.8

307.7

7139

23981

P01BA02

ATC

hydroxychloroquine; oral

2.6

307.7

4539

10601

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

307.7

11105

43347

M01AC01

ATC

piroxicam; systemic, rectal

1.9

307.7

5911

19126

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

307.7

5977

17982

M01AH05

ATC

etoricoxib; oral

2.6

307.7

38240

141609

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

307.7

4422

13513

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

307.7

5141

14873

R03DC03

ATC

montelukast; oral

2.0

307.7

9329

29496

WX002

NOMESCO Finland

Sedation and analgesia

2.1

307.7

10400

32509

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

6.4

307.7

723

672

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.8

307.7

1419

2251

K07

ICPC

Swollen ankles/oedema

2.6

307.3

2124

4897

P03

ICPC

Feeling depressed

1.8

307.2

5790

19843

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.5

305.6

520

360

M01AH03

ATC

valdecoxib; oral

2.3

305.3

2722

7088

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

304.8

2506

6289

M04AA01

ATC

allopurinol; systemic

1.8

304.4

5710

19537

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

304.3

1826

3903

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

3.0

303.7

1577

3099

N06AB06

ATC

sertraline; oral

1.8

303.5

6094

21276

J05AB01

ATC

aciclovir; systemic

1.6

302.1

10624

42821

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

301.4

3186

8917

C05AA08

ATC

fluocortolone; rectal, topical

1.7

300.8

6393

22683

XKD00

NOMESCO Finland

Uroflowmetry

1.7

300.7

6907

25043

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

299.6

1796

3837

M75.5

ICD-10 Finland

Bursitis of shoulder

3.9

299.4

1090

1681

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

299.4

12620

52895

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

298.5

3158

8840

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

297.9

6315

22386

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

297.4

9306

36494

ZXD20

NOMESCO Finland

Day surgery

1.8

297.0

5979

20881

C08CA13

ATC

lercanidipine; oral

1.7

296.8

6189

21835

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.7

296.7

1901

4211

SPAT1240

SPAT

Therapeutic discussion

1.7

295.9

5989

20948

L84

ICPC

Back syndrome without radiat pain

2.4

295.3

2383

5927

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

295.0

3318

9516

R5599

NOMESCO Finland

Other rehabilitation service

3.2

293.9

1411

2640

M23.8

ICD-10 Finland

Other internal derangements of knee

2.7

293.7

1897

4220

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

293.3

2977

8192

R25.2

ICD-10 Finland

Cramp and spasm

3.3

293.3

1349

2455

WX204

NOMESCO Finland

Axillary plexus blockaced

3.1

293.2

1455

2780

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

292.6

6305

22447

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

290.9

4185

13137

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

290.2

2254

5505

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

288.7

4298

13649

G04CA02

ATC

tamsulosin; oral

1.5

287.5

10098

40635

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

286.8

1304

2355

XF404

NOMESCO Finland

Ambulatory ECG

1.9

286.5

4056

12659

D07AD01

ATC

clobetasol; topical

1.6

283.9

7756

29395

D07AC13

ATC

mometasone; topical

1.5

283.3

14161

61313

A97

ICPC

No disease

1.6

283.3

9042

35583

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

283.3

5835

20498

SGA01

NOMESCO Finland

Emergency treatment

1.6

282.0

8458

32794

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

281.9

7624

28815

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

281.4

2759

7480

C09CA01

ATC

losartan; oral

1.5

281.3

11203

46307

N03AF01

ATC

carbamazepine; oral, rectal

2.3

280.3

2427

6233

-1, ,

NOMESCO Finland

1.4

280.2

17864

80893

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

3.1

280.1

1409

2714

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

279.7

1338

2497

N05BA12

ATC

alprazolam; oral

1.8

278.7

4769

15840

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

278.4

2483

6461

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.7

277.9

801

1017

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

277.7

5278

18104

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

34.5

277.3

270

U07

ICPC

Urine symptom/complaint other

2.0

277.3

3489

10436

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

4.0

275.5

965

1444

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

274.9

7837

29997

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.9

273.8

1534

3152

L10

ICPC

Elbow symptom/complaint

2.2

273.1

2602

6968

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.2

270.8

886

1255

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

270.2

2155

5327

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.5

269.7

1952

4603

SFA00

NOMESCO Finland

Small restoration

1.7

269.6

6719

24847

K59.0

ICD-10 Finland

Constipation

2.2

269.4

2767

7646

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.3

269.2

845

1156

A03FA02

ATC

cisapride; oral, rectal

2.0

268.1

3369

10068

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.2

268.1

1303

2456

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.4

268.1

1144

1979

J46

ICD-10 Finland

Status asthmaticus

3.0

268.0

1442

2893

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

268.0

2504

6648

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

267.9

4371

14292

SPAT1255

SPAT

Intravenous administration of medicine

2.0

267.8

3217

9454

A10BA02

ATC

metformin; oral

1.5

267.4

12749

54588

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

267.4

10941

45420

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.1

266.7

1303

2464

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

266.7

5134

17666

SPAT1058

SPAT

PEF monitoring instruction

1.9

266.3

3743

11643

D19

ICPC

Teeth/gum symptom/complaint

1.4

265.4

14499

63703

R29

ICPC

Respiratory symptom/complaint other

2.0

263.8

3329

9963

XQ800

NOMESCO Finland

Prick test

1.9

263.7

3786

11862

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

263.4

4486

14867

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

262.9

3113

9097

M03BX01

ATC

baclofen; systemic

3.7

262.7

1020

1650

A02BA04

ATC

nizatidine; systemic

2.0

262.6

3285

9799

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.1

262.0

2787

7810

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

261.8

1306

2502

EB1VA, ,

NOMESCO Finland

1.7

261.4

6110

22200

N06AX12

ATC

bupropion; oral

1.9

261.4

3966

12659

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

261.4

1836

4264

N06AA12

ATC

doxepin; systemic

2.3

261.4

2347

6123

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.4

260.8

1135

1990

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

260.7

2673

7379

J01MA14

ATC

moxifloxacin; systemic

1.9

260.4

4122

13342

AN1

Coronary angiography

1.8

259.9

4566

15277

N05CD07

ATC

temazepam; oral

1.8

259.6

5145

17848

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

259.2

2850

8092

C07AB02

ATC

metoprolol; systemic

1.6

258.0

8748

34830

SPAT1283

SPAT

Restricted health certificate

1.5

257.9

9890

40457

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

257.6

4003

12877

H92.0

ICD-10 Finland

Otalgia

2.0

257.3

3195

9502

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

257.2

2045

5046

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.8

256.4

4326

14289

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.0

256.2

3301

9952

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

255.6

12401

53206

R07.0

ICD-10 Finland

Pain in throat

1.9

255.0

3785

11990

R75

ICPC

Sinusitis acute/chronic

2.3

254.5

2393

6368

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

27.0

254.5

262

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

254.2

3199

9560

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

253.6

6553

24433

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.5

253.4

1040

1751

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.5

253.0

1047

1773

J01CF05

ATC

flucloxacillin; systemic

2.0

252.8

3062

9021

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

252.6

1863

4433

L60.0

ICD-10 Finland

Ingrowing nail

2.3

252.3

2360

6266

K85

ICPC

Elevated blood pressure

1.6

252.2

6773

25498

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

252.1

2485

6747

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

251.6

3290

9969

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

251.2

1359

2735

TAB00

NOMESCO Finland

Lumbar puncture

2.3

251.0

2277

5966

L04AA13

ATC

[U] leflunomide

3.2

250.9

1202

2245

R06AX22

ATC

ebastine; oral

1.6

250.4

8336

33030

Z00.8

ICD-10 Finland

Other general examinations

1.9

250.3

4038

13145

S01

ICPC

Pain/tenderness of skin

2.3

250.0

2243

5848

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.6

249.7

1009

1680

S04

ICPC

Lump/swelling localized

1.7

249.7

5117

17914

S83.2

ICD-10 Finland

Tear of meniscus, current

2.0

248.6

3231

9768

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

248.6

3300

10053

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.8

248.5

918

1431

M75

ICD-10 Finland

Shoulder lesions

2.4

248.4

2024

5051

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

247.3

15195

68035

M02AA15

ATC

diclofenac; topical

2.0

247.2

3109

9287

H29

ICPC

Ear symptom/complaint other

1.7

246.7

5277

18696

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

245.7

2634

7400

M09AX01

ATC

hyaluronic acid; parenteral

2.5

245.6

1903

4637

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.5

245.3

1866

4507

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

245.1

13981

61754

J01DA06

ATC

[U] cefuroxime

1.6

244.1

6781

25730

M22.4

ICD-10 Finland

Chondromalacia patellae

2.7

243.8

1526

3335

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.6

242.9

955

1559

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

242.9

11868

50915

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

+∞

242.8

290

P76

ICPC

Depressive disorder

1.9

242.8

3610

11436

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.8

242.7

896

1396

L92

ICPC

Shoulder syndrome

3.5

242.6

997

1680

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

242.1

2101

5396

U01

ICPC

Dysuria/painful urination

1.9

241.8

3797

12247

G56.4

ICD-10 Finland

Causalgia

12.9

241.2

323

147

Z2446

NOMESCO Finland

Social worker

1.9

241.1

3434

10719

C09AA05

ATC

ramipril; oral

1.5

240.9

10647

44778

J01FA15

ATC

telithromycin; oral

1.8

240.4

4493

15302

SDA03

NOMESCO Finland

Periodontal treatment

1.4

240.3

20371

96135

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

240.3

4879

17025

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

239.1

4909

17183

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

239.0

5159

18315

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

47.7

238.2

219

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

238.0

2815

8215

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

238.0

2269

6072

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

237.5

2396

6566

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

236.8

2077

5359

ACC53

NOMESCO Finland

Release of ulnar nerve

4.4

236.6

732

989

K04.0

ICD-10 Finland

Pulpitis

1.7

236.6

4885

17125

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

236.1

1673

3901

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

235.7

6193

23160

T82

ICPC

Obesity

2.3

235.6

2092

5427

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.7

234.9

898

1436

P20

ICPC

Memory disturbance

1.7

234.4

5194

18568

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.4

234.4

716

957

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

234.3

2243

6012

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

233.7

1596

3652

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

233.7

3398

10679

F29

ICPC

Eye symptom/complaint other

1.8

232.9

4577

15816

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

232.8

5008

17757

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.7

232.2

890

1426

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.8

232.0

868

1366

A07AA02

ATC

nystatin; oral

2.1

231.6

2603

7448

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

231.5

2510

7080

NF3AA

NOMESCO Finland

Femur X-ray examination

3.3

231.2

1041

1867

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.2

230.9

759

1079

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

230.6

5344

19335

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

230.1

17597

81541

B01AB10

ATC

tinzaparin; parenteral

1.8

229.7

4533

15679

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

229.4

6363

24107

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

229.1

5720

21104

S20.2

ICD-10 Finland

Contusion of thorax

2.1

228.7

2521

7157

N03AX11

ATC

topiramate; oral

2.8

228.6

1354

2870

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.2

228.5

2286

6241

1220

FHL

Arthroscopy

2.5

228.4

1651

3888

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.1

228.0

1124

2137

A01AB09

ATC

miconazole; local oral

1.8

227.2

3918

13011

I20.09

ICD-10 Finland

Unstable angina

2.2

226.5

2372

6598

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

226.4

3086

9481

K80

ICPC

Cardiac arrhythmia NOS

1.9

226.0

3531

11362

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

225.7

1545

3539

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

225.3

3758

12349

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.7

225.1

646

817

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

81.5

224.9

194

M19.2

ICD-10 Finland

Other secondary arthrosis

4.8

224.9

627

772

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

3.6

224.9

878

1426

H02

ICPC

Hearing complaint

1.6

224.7

5671

20974

N06AX03

ATC

mianserin; oral

2.2

224.1

2185

5900

P01

ICPC

Feeling anxious/nervous/tense

1.6

223.3

6890

26767

ZY010

NOMESCO Finland

Hospital outpatient

2.0

223.0

2814

8408

G04BD08

ATC

solifenacin; oral

2.0

222.3

2735

8096

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

221.9

1376

2991

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

221.8

5727

21302

NH1AD

NOMESCO Finland

Ankle and foot CT

3.0

220.7

1173

2335

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

220.5

4412

15315

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

220.2

1490

3392

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

219.6

3579

11672

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

219.3

1426

3180

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.6

217.7

882

1471

SPAT1252

SPAT

Overall medication plan or its review

1.9

217.5

2997

9239

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

217.5

2351

6621

M62.6

ICD-10 Finland

Muscle strain

2.6

217.1

1453

3289

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

217.1

904

1537

N02AC04

ATC

dextropropoxyphene; oral

2.6

215.7

1502

3470

ZA1.0

ICD-10 Finland

Shoulder region

3.1

215.5

1066

2031

K04.08

ICD-10 Finland

Other specified pulpit

1.8

215.0

3910

13190

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

215.0

6432

24791

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.7

214.9

1388

3084

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.4

213.4

936

1649

SPAT1202

SPAT

Intra-articular injection

2.8

213.0

1276

2721

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

212.4

2612

7728

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

212.4

2500

7277

L99

ICPC

Musculoskeletal disease other

3.1

212.2

1032

1945

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

212.0

2010

5362

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

211.6

1814

4630

L01BA01

ATC

methotrexate; systemic

2.4

211.6

1699

4208

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

211.4

2519

7365

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

211.3

2916

8992

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

210.9

2041

5492

M70.2

ICD-10 Finland

Olecranon bursitis

2.8

210.6

1260

2685

M01AE52

ATC

naproxen and esomeprazole; oral

2.7

210.6

1369

3052

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

5.5

210.5

510

547

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

210.5

3795

12767

WX702

NOMESCO Finland

Supraglottic ventilation device

2.0

210.4

2547

7491

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.4

210.2

1660

4079

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

209.8

3711

12410

G43.3

ICD-10 Finland

Complicated migraine

3.2

209.8

987

1821

H13

ICPC

Plugged feeling ear

1.5

209.6

8420

34621

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.4

209.5

641

858

D12

ICPC

Constipation

2.4

209.4

1677

4148

R06.5

ICD-10 Finland

Mouth breathing

1.8

208.8

4094

14118

J01

ICD-10 Finland

Acute sinusitis

2.0

208.2

2713

8198

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.8

208.0

1252

2677

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.3

207.4

1847

4795

R01AD01

ATC

beclometasone; nasal

1.5

207.4

6984

27645

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

207.2

2278

6457

N06AX26

ATC

vortioxetine; oral

1.8

207.2

3798

12839

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

206.8

10280

44064

C01CA24

ATC

epinephrine; parenteral

1.9

205.8

3114

9907

K29

ICPC

Cardiovascular sympt/complt other

2.3

205.4

1874

4916

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.6

205.2

1456

3395

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

205.2

4596

16450

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.3

205.1

944

1717

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

204.7

5246

19452

N03AG01

ATC

valproic acid; systemic, rectal

1.9

204.3

3037

9604

S76

ICPC

Skin infection other

2.0

204.2

2442

7148

NG2AA

NOMESCO Finland

Patella X-ray examination

2.8

204.1

1205

2549

M01AB01

ATC

indometacin; systemic, rectal

1.9

203.6

2986

9400

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

203.3

9817

41833

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

203.0

3858

13179

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

202.8

2921

9138

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

201.7

241

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

7.3

201.3

382

308

S22

ICPC

Nail symptom/complaint

1.9

201.2

2919

9154

JAH01

NOMESCO Finland

Laparoscopy

2.1

200.5

2154

6048

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.0

200.3

2673

8143

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

200.3

2395

7010

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.6

200.3

1408

3268

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.0

199.9

688

1015

R10.0

ICD-10 Finland

Acute abdomen

2.4

199.9

1640

4102

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

6.0

199.8

446

438

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

199.6

2198

6232

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

199.4

4011

13928

U05

ICPC

Urination problems other

2.1

199.1

2201

6250

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

198.9

6917

27554

J02AC02

ATC

itraconazole; systemic

1.5

198.6

7866

32214

UJD02

NOMESCO Finland

Gastroscopy

2.1

198.6

2082

5789

WX892

NOMESCO Finland

Monitored bed care

1.8

198.6

3469

11551

C03DA01

ATC

spironolactone; oral

1.6

198.4

5140

19103

ZX120

NOMESCO Finland

Intravenous

1.7

198.3

4282

15167

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

197.6

1320

2984

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

196.9

2554

7701

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.8

196.8

736

1158

D82

ICPC

Teeth/gum disease

1.3

195.5

18986

90704

B02AA02

ATC

tranexamic acid; systemic

1.5

195.2

6707

26638

WZC00, ,

SPAT

1.6

195.1

4930

18203

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

4.7

194.9

550

685

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

194.3

4132

14570

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

194.1

1852

4952

U04

ICPC

Incontinence urine

2.1

193.5

2195

6295

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

193.4

1508

3682

M15.8

ICD-10 Finland

Other polyarthrosis

3.5

193.3

803

1363

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

193.0

1767

4641

N39.3

ICD-10 Finland

Stress incontinence

1.9

192.7

2914

9263

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

192.7

5257

19785

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

192.2

5636

21584

SPAT1104

SPAT

Monitoring of emergency patient

1.9

191.9

2942

9395

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

7.4

191.8

361

288

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

191.7

1403

3322

M05BA04

ATC

alendronic acid; oral

1.8

191.5

3276

10835

R31

ICD-10 Finland

Unspecified haematuria

1.7

191.3

4361

15670

SPAT1325

SPAT

Vaccination

1.3

191.1

15644

72800

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

190.9

2465

7419

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

190.8

2010

5598

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

190.8

4395

15836

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

190.7

1758

4631

R1250

NOMESCO Finland

Evaluation of functional capability

2.9

190.6

1090

2264

P29

ICPC

Psychological sympt/compl other

1.7

190.3

3792

13126

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

190.0

2160

6200

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

4.5

189.7

566

741

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

3.7

188.3

717

1143

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

188.3

4368

15766

M79.4

ICD-10 Finland

Hypertrophy of (infrapatellar) fat pad

232.5

188.2

238

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

188.2

2583

7944

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

188.1

1901

5206

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.7

188.0

1178

2574

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

187.7

3520

11968

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

187.6

2127

6098

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

187.0

7835

32421

J05AB11

ATC

valaciclovir; oral

1.5

186.9

6463

25688

Z01.7

ICD-10 Finland

Laboratory examination

1.5

186.8

6855

27597

R03AC13

ATC

formoterol; inhalant

2.1

186.7

2158

6233

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.2

186.7

1909

5253

A06AC51

ATC

ispaghula, combinations; oral

2.1

186.6

2161

6246

NF1DA

NOMESCO Finland

X-ray of hips

3.1

186.5

907

1709

B01AB04

ATC

dalteparin; parenteral

2.0

186.5

2377

7120

A10AE04

ATC

insulin glargine; parenteral

1.7

186.3

4162

14870

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

186.2

855

1553

TQW40, ,

SPAT

1.8

185.0

3096

10166

OAB93, ,

SPAT

1.9

184.8

2884

9261

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.3

183.5

1627

4213

S15

ICPC

Foreign body in skin

1.9

183.2

2771

8806

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.0

183.0

937

1823

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

182.8

2164

6307

C10AC01

ATC

colestyramine; oral

2.6

182.6

1268

2924

R06AE09

ATC

levocetirizine; oral

1.5

182.3

6874

27822

C10AA03

ATC

pravastatin; oral

1.9

182.3

2772

8825

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

181.5

13739

63069

J01MA06

ATC

norfloxacin; oral

1.6

181.4

5611

21740

S10

ICPC

Boil/carbuncle

1.9

181.1

2694

8514

207

Kela drug reimbursment

Chronic arrhythmias

1.5

180.6

6051

23870

R01AD11

ATC

triamcinolone; nasal

1.7

180.6

3886

13738

M10.0

ICD-10 Finland

Idiopathic gout

2.4

180.3

1428

3512

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

180.1

4754

17730

M25.2

ICD-10 Finland

Flail joint

4.3

180.0

569

783

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

179.9

2576

8036

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.6

179.8

1227

2804

WX704

NOMESCO Finland

Intubation

1.7

179.5

3671

12793

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

179.4

1656

4364

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

4.3

179.1

566

779

RF210, ,

NOMESCO Finland

2.6

178.8

1258

2920

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.5

178.6

1299

3066

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

178.5

1577

4077

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

23.4

178.4

191

N06AB05

ATC

paroxetine; oral

1.9

178.1

2813

9066

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.1

177.9

1979

5630

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

177.8

2196

6501

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.4

177.7

781

1378

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.6

177.6

521

672

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.0

177.5

610

899

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

177.4

212

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1766

3600

2.93

319.95

1.8

1.5

—

(3025159) Blasts/100 leukocytes in Blood

5578

18702

1.82

318.50

4.4

4.2

0.26

0.35

0.33

1526

4998

(3041096) Erythrocytes [Presence] in Urine by Automated

16684

73300

1.46

316.37

4.0

2.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

819

943

5.15

315.16

1.5

1.3

5.49

6.05

u/l

0.69

687

787

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4453

13921

1.94

314.15

1.6

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2587

6510

2.39

312.97

2.5

2.4

0.76

0.92

g/l

1.16

2261

5550

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4735

15148

1.90

312.16

3.8

3.9

5.16

5.12

kpa

2.37

4500

14335

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5420

18180

1.82

308.53

3.1

2.8

200.95

210.67

ng/l

0.70

4897

16489

(3028026) IgM [Mass/volume] in Serum or Plasma

4539

14376

1.92

308.08

1.9

1.25

1.31

g/l

1.15

4140

13153

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

56261

276820

3.80

307.65

20.0

11.7

20.47

24.07

mg/l

133.02

48231

212418

(40768804) Tissue Pathology biopsy report

24055

105306

1.56

307.65

2.2

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

17461

63966

1.84

307.65

4.8

3.8

91.07

90.48

2.15

16977

62369

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10997

36507

1.94

307.65

2.4

2.2

29.98

29.84

1.32

10677

35429

(3000991) Gas panel - Venous blood

6039

20366

1.82

307.65

8.9

8.5

—

(3007461) Platelets [#/volume] in Blood

58357

316997

3.36

307.65

28.6

17.3

255.25

253.16

e9/l

11.25

57508

307819

(3013512) EKG study

17279

67178

1.71

307.65

4.3

3.5

—

(3021589) Normoblasts [#/volume] in Blood

27753

119107

1.68

307.65

11.5

8.8

0.00

e9/l

0.73

22896

97352

(3018418) pH of Serum or Plasma

20088

69734

2.03

307.65

4.6

4.0

7.40

0.94

3817

13687

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

51873

268307

1.94

307.65

4.7

3.9

4.61

4.69

mmol/l

56.76

48605

250720

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3366

7218

2.83

307.65

2.4

2.3

357.94

611.71

ug/l

2.24

3106

6726

(3004588) Protein electrophoresis panel - Serum or Plasma

5140

13598

2.33

307.65

2.3

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

30951

129796

1.82

307.65

4.3

3.2

0.00

estimate

0.48

6693

26258

(3017181) Myelocytes/100 leukocytes in Blood

6146

20702

1.82

307.65

4.4

4.1

0.89

0.96

0.95

2062

6918

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

51990

258746

2.28

307.65

4.9

4.0

5.95

5.83

mmol/l

69.13

48138

237423

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3061

7123

2.60

307.65

1.8

1.7

1.19

1.16

g/l

6.13

2915

6780

(3048689) Calprotectin [Mass/mass] in Stool

9762

32677

1.90

307.65

2.4

2.5

124.56

134.32

ug/g

1.41

7729

25949

(3011397) Hemoglobin [Presence] in Urine by Test strip

15244

58741

1.70

307.65

4.1

3.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3583

9805

2.21

307.65

1.5

1.6

10.20

14.10

u/ml

0.85

310

(3002032) Base excess in Venous blood by calculation

6708

22185

1.87

307.65

5.1

4.0

1.84

1.78

mmol/l

0.69

5826

18615

(3008898) HLA-B27 [Presence]

3523

8170

2.62

307.65

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8365

24930

2.12

307.65

1.9

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

37537

150740

2.21

307.65

9.6

9.0

4.16

4.10

e9/l

4.64

33232

131105

(3042936) Bacteria identified in Isolate by Culture

10907

32355

2.19

307.65

2.3

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

6520

20536

1.96

307.65

7.2

7.3

1.34

1.37

mmol/l

1.25

6374

19982

(3019550) Sodium [Moles/volume] in Serum or Plasma

56081

277142

3.61

307.65

21.3

13.4

139.55

139.62

mmol/l

7.70

55219

268921

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32555

119496

2.29

307.65

7.5

6.4

1.21

mmol/l

3.99

28174

100751

(3000494) Fungus identified in Specimen by Culture

8104

27938

1.81

307.65

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4060

8410

2.96

307.65

1.3

1.2

1.06

0.81

u/ml

0.58

400

611

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

46873

197067

2.76

307.65

8.7

7.0

76.90

78.27

u/l

8.11

44692

185279

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2671

6053

2.66

307.65

1.3

28.64

41.74

u/ml

1.32

127

401

(3012544) pH of Venous blood

6886

23012

1.85

307.65

5.0

4.0

7.36

7.39

2.13

161

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3007

7661

2.37

307.65

2.2

2.3

7.37

7.35

g/l

0.35

2751

6860

(3003396) Base excess in Arterial blood by calculation

7638

25879

1.84

307.65

7.2

7.6

1.04

0.98

mmol/l

0.66

6163

20431

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9153

31421

1.83

307.65

6.7

5.9

1.05

mmol/l

1.22

8600

29299

(3027945) Reticulocytes/100 erythrocytes in Blood

7563

26004

1.81

307.65

2.7

2.6

1.80

1.73

6.58

6706

22978

(3044889) 12 lead EKG panel

39269

178190

1.83

307.65

4.1

3.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

11633

42680

1.74

307.65

2.8

3.0

2.44

2.45

mmol/l

0.17

10075

37141

(3020630) Protein [Mass/volume] in Serum or Plasma

6141

17255

2.21

307.65

2.5

2.6

66.49

66.57

g/l

0.34

5633

15673

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

29804

123345

1.82

307.65

2.9

2.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2466

5560

2.67

307.65

1.3

9.13

10.21

u/ml

0.27

351

883

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10655

35083

1.95

307.65

2.8

2.4

2.36

g/l

0.15

9877

32346

(3000475) Leukocytes [#/volume] in Synovial fluid

2363

4060

3.51

307.65

1.7

1.6

12232.72

13810.09

e6/l

0.76

1699

2961

(3005719) IgG [Mass/volume] in Serum or Plasma

6002

18426

2.01

307.65

2.7

10.28

10.70

g/l

10.61

5508

16862

(3022145) Colonoscopy Study observation

7674

27308

1.74

307.65

1.3

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

31107

131212

1.80

307.65

4.4

3.3

0.00

estimate

0.08

6237

24494

(3022948) Iron [Moles/volume] in Serum or Plasma

11513

38188

1.95

307.65

2.8

2.4

12.88

13.98

umol/l

1.39

10755

35569

(3023103) Potassium [Moles/volume] in Serum or Plasma

56148

278068

3.62

307.65

21.5

13.5

3.96

3.95

mmol/l

26.36

55205

269196

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

14303

34912

2.84

307.65

1.4

1.2

11.67

11.38

u/ml

0.11

5266

14056

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

33907

128433

2.25

307.65

6.3

6.1

10.48

11.73

umol/l

67.54

32259

121251

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8481

28172

1.89

307.65

2.9

2.8

7.09

9.09

umol/l

14.61

7255

24308

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16087

60850

1.75

307.65

2.7

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25095

87661

2.16

307.65

4.3

3.1

61.33

62.84

ng/l

0.03

16531

54997

(3026493) Urate [Moles/volume] in Serum or Plasma

18540

61107

2.12

307.65

2.8

2.5

2893.83

4703.05

umol/l

9.07

16240

54210

(3021440) Promyelocytes/100 leukocytes in Blood

5848

19727

1.82

307.65

4.4

4.1

0.10

0.12

0.90

1770

5984

(3027801) Oxygen [Partial pressure] in Arterial blood

7644

25831

1.84

307.65

7.2

7.6

12.16

12.76

kpa

17.23

7307

24609

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2812

7180

2.36

307.65

2.2

2.3

9.79

10.41

g/l

10.63

2540

6338

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4603

12875

2.19

307.65

1.8

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

29769

107656

2.22

307.65

6.8

5.9

1.21

mmol/l

4.12

27572

98175

(3002030) Lymphocytes/100 leukocytes in Blood

32478

127940

2.05

307.65

7.1

5.9

28.14

28.34

2.58

30671

120378

(40758558) Short blood count panel - Blood

16993

64523

1.76

307.65

7.1

7.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2424

5495

2.65

307.65

1.3

10.24

6.36

u/ml

0.66

238

591

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27004

103673

1.95

307.65

2.6

2.2

3406.78

75.70

nmol/l

0.50

24614

94048

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

38869

197098

1.44

307.65

3.6

3.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

58372

317511

3.33

307.65

28.7

17.4

134.40

135.97

g/l

123.81

57960

312674

(3023368) Bacteria identified in Blood by Culture

18716

63586

2.05

307.65

4.9

4.0

—

(3019198) Lymphocytes [#/volume] in Blood

34456

134213

2.17

307.65

6.8

5.7

1.94

e9/l

0.01

31007

118680

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2525

6175

2.46

307.65

1.5

1.4

284.30

272.67

ug/g

1.68

1424

3524

(3023520) Reticulocytes [#/volume] in Blood

5720

18701

1.88

307.65

2.7

2.6

71.24

69.06

e9/l

3.71

4215

13933

(3012516) Albumin [Mass/volume] in Urine

16697

67381

1.62

307.65

3.5

3.2

629.76

359.46

mg/l

7.33

11015

43199

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5576

14426

2.39

307.65

1.3

1.2

45.66

50.82

au/ml

0.66

170

792

(3019150) Specific gravity of Urine by Refractometry

13776

55761

1.58

307.65

4.6

3.5

1.02

kg/l

0.37

2181

8552

(3001122) Ferritin [Mass/volume] in Serum or Plasma

29195

121198

1.80

307.65

3.3

2.8

114.89

115.23

ug/l

0.07

27178

113082

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5690

18325

1.90

307.65

2.6

2.2

6.04

7.91

ug/l

8.31

4974

15848

(3037467) Urinalysis macro (dipstick) panel - Urine

42686

182903

2.25

307.65

5.3

3.8

—

(3009508) Creatinine [Moles/volume] in Urine

18756

76247

1.64

307.65

3.5

3.2

7.60

7.89

mmol/l

12.09

15849

64993

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11537

39055

1.90

307.65

3.4

2.7

2.91

3.03

e6/l

0.49

6405

20628

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

23258

101480

1.56

307.65

4.6

3.3

—

(36304419) Bacteria [Presence] in Urine

19005

67082

1.96

307.65

3.7

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

19452

68417

1.98

307.65

3.7

2.9

0.35

0.43

e6/l

5.19

15268

50932

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2537

4733

3.23

307.65

1.5

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22744

67178

2.58

307.65

2.5

2.0

193.33

220.90

u/l

2.40

21579

62835

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6038

15798

2.38

307.65

2.5

2.3

20.29

22.83

au/ml

1.10

387

1396

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

20081

50143

3.02

307.65

2.0

1.7

1.02

1.28

mg/l

23.06

15317

37586

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

49822

256698

1.79

307.65

4.2

3.5

1.36

1.27

mmol/l

98.50

46174

237482

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8332

25107

2.10

307.65

1.9

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

16216

60135

1.79

307.65

1.3

1.39

1.81

u/ml

4.32

4267

16432

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

56757

296333

3.04

307.65

13.0

8.9

26.60

26.54

u/l

0.21

55427

285561

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2044

4356

2.81

307.65

1.3

1.2

6.02

18.39

u/ml

1.11

(3044941) Cell count panel - Synovial fluid

1561

2665

3.50

307.65

1.5

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

32113

121640

2.17

307.65

7.2

6.3

—

(3002582) Erythrocytes [#/volume] in Urine

21062

75382

1.98

307.65

3.8

3.0

65.58

101.90

e6/l

2.74

16675

56677

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

45632

208531

2.16

307.65

4.6

3.8

14.66

pmol/l

0.15

42138

190024

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3058

6678

2.77

307.65

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

51955

251193

2.52

307.65

5.6

4.3

1.87

2.16

mu/l

4.90

48549

231528

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6358

21167

1.85

307.65

8.0

8.4

121.72

121.82

g/l

0.13

6200

20604

(3010813) Leukocytes [#/volume] in Blood

58378

317404

3.35

307.65

28.6

17.3

6.92

6.72

e9/l

37.77

57421

307268

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6725

22276

1.87

307.65

5.0

4.0

5.88

5.81

kpa

5.86

6542

21566

(3002385) Erythrocyte distribution width [Ratio]

47983

244802

1.72

307.65

22.6

14.3

14.95

14.88

0.24

47514

239807

(3013115) Eosinophils [#/volume] in Blood

34679

134034

2.21

307.65

7.0

6.0

0.19

e9/l

1.74

30947

117375

(3013707) Erythrocyte sedimentation rate by Westergren method

46372

190171

2.85

307.65

5.2

3.5

12.00

11.33

mm/h

18.56

43736

175520

(3026361) Erythrocytes [#/volume] in Blood

58372

317369

3.34

307.65

28.5

17.3

4.47

4.53

e12/l

124.98

57399

307259

(3002179) Metamyelocytes/100 leukocytes in Blood

5691

18861

1.85

307.65

4.1

3.9

0.58

0.70

2.80

1842

5915

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2850

7206

2.38

307.65

2.3

2.92

2.95

g/l

0.67

2597

6409

(3015736) pH of Urine

25359

105305

1.71

307.65

3.9

3.0

5.89

5.91

0.39

1700

9202

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17887

61807

1.99

307.65

2.5

2.2

2.90

2.91

mg/l

0.29

15546

52563

(3016502) Oxygen saturation in Arterial blood

6900

22893

1.86

307.65

7.5

8.0

95.71

95.69

0.10

6653

22030

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22536

75978

2.18

307.65

3.0

2.4

56.32

62.78

u/l

3.64

21027

70004

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11676

38430

1.97

307.65

3.5

3.6

0.82

mmol/l

3.80

10939

36006

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3000

7657

2.36

307.65

2.2

2.3

—

(3019069) Monocytes/100 leukocytes in Blood

31819

123354

2.08

307.65

7.3

6.1

8.44

8.48

1.45

29990

115674

(3018095) Leukocytes [#/volume] in Urine

23921

89843

1.93

307.65

4.5

3.4

70.61

102.83

e6/l

8.17

17731

61200

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22034

85955

1.79

307.65

3.5

3.2

32.53

33.74

u/l

0.75

20941

81461

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9944

32593

1.94

307.65

2.9

2.5

22.00

23.09

10.55

8515

27960

(3035941) MCH [Entitic mass]

58370

317288

3.35

307.65

28.4

17.2

30.24

30.18

13.49

57953

312430

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7139

22762

1.95

307.65

2.9

2.4

58.48

42.68

u/l

0.66

6129

19532

(3021788) Differential panel - Synovial fluid

1884

3179

3.55

307.65

1.6

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

27934

105659

2.02

307.65

5.2

4.8

35.68

35.73

g/l

0.81

26136

97893

(3005322) IgE [Units/volume] in Serum or Plasma

5090

16250

1.91

307.65

1.3

192.60

280.50

u/ml

7.36

4730

15015

(3020564) Creatinine [Moles/volume] in Serum or Plasma

56919

294159

3.34

307.65

21.6

13.5

77.25

75.87

umol/l

15.14

56904

294011

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14977

37736

2.76

307.65

1.4

1.2

33.56

34.78

iu/ml

0.17

4534

12092

(3001604) Monocytes [#/volume] in Blood

33743

129303

2.20

307.65

6.8

5.7

0.58

e9/l

0.52

29677

111852

(3029937) Albumin [Presence] in Urine by Test strip

16882

69571

1.59

307.65

4.8

3.5

0.00

estimate

0.78

6200

24084

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7868

27146

1.80

307.65

4.0

4.3

237.79

244.55

u/l

2.82

7431

25721

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12340

41060

1.96

307.65

3.2

2.6

1.06

1.21

e6/l

1.00

7194

22486

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18130

60842

2.07

307.65

3.2

2.9

1368.68

1463.64

ng/l

1.54

15260

51468

(3024354) Oxygen [Partial pressure] in Venous blood

5545

18320

1.85

307.65

4.4

3.4

4.62

4.68

kpa

0.99

5363

17664

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

39395

186785

1.68

307.65

3.7

2.8

48.71

44.87

u/l

13.00

37117

175571

(3021601) Nitrite [Presence] in Urine by Test strip

30852

129884

1.80

307.65

5.8

4.4

0.00

estimate

3.03

6402

25191

(3006315) Basophils [#/volume] in Blood

33824

129590

2.20

307.65

6.8

5.7

0.04

e9/l

3.21

29711

112007

(3000850) Epithelial cells [#/volume] in Urine

15258

51153

2.00

307.65

3.0

2.5

5.77

5.91

e6/l

0.37

13785

45504

(3007164) IgA [Mass/volume] in Serum or Plasma

14245

52180

1.78

307.65

1.6

1.4

2.34

2.33

g/l

0.22

8583

32442

(3026008) Bacteria identified in Urine by Culture

20306

74609

1.90

307.65

3.5

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2995

7642

2.36

307.65

2.2

2.3

3.68

3.75

g/l

1.57

2743

6847

(3024731) MCV [Entitic volume]

58370

317331

3.34

307.65

28.4

17.3

90.93

90.46

108.18

57950

312458

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15327

64660

1.52

307.65

1.7

1.6

1.46

1.36

mmol/l

28.18

12942

54773

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7650

25844

1.84

307.65

7.2

7.6

5.09

5.08

kpa

0.35

7307

24633

(3020682) Albumin/Creatinine [Ratio] in Urine

17532

71000

1.63

307.65

4.1

3.8

11.39

9.48

mg/mmol

3.42

11163

45465

(3021960) Folate [Moles/volume] in Serum or Plasma

15704

52937

2.00

307.65

1.6

1.5

20.11

20.08

nmol/l

0.08

13733

45777

(3022217) INR in Platelet poor plasma by Coagulation assay

30526

109164

2.29

307.65

16.1

13.3

1.23

1.25

inr

1.47

9474

32623

(3031040) Bacteria [#/volume] in Urine by Automated count

40937

173922

2.18

307.65

5.6

3.9

1072.62

1419.79

e6/l

0.58

475

2542

(3006504) Eosinophils/100 leukocytes in Blood

31706

122578

2.09

307.65

7.0

5.9

2.82

2.84

0.56

29832

114776

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13823

44014

2.09

307.65

4.4

3.3

297.41

617.30

ng/l

11.09

10017

32352

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

13197

50738

1.67

307.65

1.7

1.6

48282875.10

30671018.01

pmol/l

1.95

11004

42187

(3037522) Nuclear Ab [Titer] in Serum

12196

31807

2.56

307.65

1.4

1.3

497.04

550.31

titre

2.10

2453

6224

(3026782) Osmolality of Urine

14312

49453

1.91

307.65

3.3

2.7

533.69

550.28

mosm/kgh2o

13.77

12401

42288

(40768797) Stomach Pathology biopsy report

10202

31187

2.10

307.65

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

8606

29260

1.84

307.65

7.6

7.2

104.51

104.50

mmol/l

0.05

8601

29238

(3019309) Folate [Moles/volume] in Red Blood Cells

12421

42214

1.91

307.65

1.8

1.7

1149.46

1169.05

nmol/l

1.40

9617

31854

(3044640) Blood type and Crossmatch panel - Blood

20838

81064

1.77

307.65

2.7

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5453

16394

2.04

307.65

4.1

4.0

91.75

89.96

ng/l

0.58

4779

14180

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

52671

272446

2.04

307.65

5.2

4.2

2.73

2.80

mmol/l

48.40

49067

253264

(3015377) Calcium [Moles/volume] in Serum or Plasma

21399

81739

1.83

307.65

3.2

3.4

2.35

mmol/l

4.80

18885

72370

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7591

22108

2.16

307.65

2.2

358.43

383.24

nmol/l

20.61

7000

20419

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2997

6932

2.61

307.65

1.8

1.7

0.24

0.23

g/l

2.26

2855

6576

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5655

16654

2.09

307.65

1.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

32125

125832

2.06

307.65

6.8

5.7

57.11

57.02

0.73

30317

118306

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

51450

266277

1.89

307.65

4.6

3.9

1.42

1.46

mmol/l

65.10

47990

247859

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11948

37140

2.10

307.65

2.0

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

9348

28423

2.10

307.65

2.0

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26432

97176

2.06

307.65

2.1

1.8

96.22

95.50

pmol/l

1.45

14397

51698

(3009542) Hematocrit [Volume Fraction] of Blood

58342

316636

3.37

307.65

28.7

17.4

40.02

40.57

13.88

55430

297683

(3013826) Glucose [Moles/volume] in Serum or Plasma

37413

147818

2.27

307.65

5.6

4.5

6.62

6.65

mmol/l

1.88

35546

135919

(3022096) Basophils/100 leukocytes in Blood

30845

118466

2.07

307.65

7.0

5.9

0.67

1.42

28940

110555

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

49534

240666

2.15

307.65

6.3

5.0

39.83

38.96

mmol/mol

70.31

46341

223447

(40761511) CBC panel - Blood by Automated count

56078

292758

2.72

307.65

17.8

11.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

51791

255381

2.32

307.65

17.1

11.1

83.84

85.15

ml/min/173m2

29.91

44484

206640

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1999

4469

2.68

306.82

1.3

1.2

3.01

5.94

u/ml

1.34

139

348

(3009343) pH of Capillary blood

4675

14981

1.90

306.43

3.8

3.9

7.42

0.01

674

1910

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3417

9842

2.10

300.69

1.9

2.0

39.19

39.27

u/l

0.08

3075

8810

(3019225) pH of Specimen

6319

22378

1.73

299.24

4.5

4.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4531

14520

1.90

296.55

3.7

3.9

1.57

1.63

mmol/l

0.53

3339

10512

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13459

57412

1.48

291.84

1.8

1.6

—

(36660697) Celiac disease serology panel - Serum

6052

21336

1.74

290.62

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6063

21392

1.73

290.31

8.7

7.4

9.58

9.44

mmol/l

0.69

5789

20333

(4200892) Spirometry reversibility

4956

16463

1.83

290.09

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1252

2206

3.37

285.69

1.6

1.5

55.79

57.08

0.43

796

1432

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2361

5953

2.38

283.95

2.2

38.02

37.72

g/l

1.39

2097

5146

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1979

4606

2.57

280.79

1.3

1.2

40.76

44.68

u/ml

0.39

203

432

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2306

5785

2.39

280.32

2.3

2.2

0.03

g/l

0.26

2137

5249

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2821

7772

2.18

276.79

1.6

231.64

299.53

titre

0.63

119

321

(3013139) Helicobacter pylori Ag [Presence] in Stool

4842

16195

1.82

276.66

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3827

11980

1.93

267.35

5.6

4.5

24.15

24.00

mmol/l

1.93

3761

11686

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6268

22902

1.67

262.73

2.3

2.4

0.22

0.21

g/l

3.50

5794

21306

(3019060) Gas panel - Arterial blood

4378

14417

1.84

262.23

4.7

4.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2135

5342

2.39

260.73

2.3

2.2

0.00

g/l

0.51

1969

4825

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2101

5272

2.38

254.92

2.4

2.3

0.00

g/l

-0.00

1960

4815

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6536

24536

1.63

245.69

3.9

3.2

—

(40761535) Cells panel - Urine sediment

5263

18678

1.71

244.43

3.9

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4747

16365

1.76

243.96

3.1

3.5

4.45

4.56

pmol/l

8.38

4178

14689

(3025941) Bacteria identified in Stool by Culture

4444

15091

1.78

240.12

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4152

13814

1.82

239.85

4.4

3.3

128.71

129.64

g/l

1.71

4050

13506

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4539

15520

1.77

239.66

7.6

7.7

24.82

24.69

mmol/l

1.49

4504

15361

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3796

12312

1.86

237.51

9.1

10.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3328

10341

1.94

236.65

1.8

1.7

1.53

1.49

g/l

1.43

2863

8794

(3045414) Leukocytes [Presence] in Urine

3356

10491

1.93

234.44

1.9

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5422

19676

1.68

231.38

4.2

3.7

1.22

1.23

mmol/l

2.37

4795

17083

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3351

10520

1.92

231.10

3.9

3.0

1.40

1.27

6.76

3336

10467

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3632

11717

1.87

230.82

2.4

2.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4114

13831

1.80

229.35

7.1

24.72

24.49

mmol/l

3.44

3933

13145

(3014007) Fractional oxyhemoglobin in Arterial blood

4220

14305

1.78

228.92

9.3

9.7

93.82

93.97

0.83

4204

14248

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2240

6099

2.20

225.29

1.4

493.17

547.90

mg/l

1.73

2149

5807

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3274

10312

1.91

223.41

3.9

2.9

0.65

0.66

1.05

3265

10274

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4190

14288

1.77

222.57

9.2

9.6

0.66

0.68

3.20

4165

14201

(3004616) Nuclear Ab [Presence] in Serum

1227

2504

2.91

221.33

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4179

14292

1.77

219.71

9.1

9.5

1.43

1.37

2.87

4155

14193

(3036489) Thrombin time

3119

9732

1.93

218.66

2.4

2.2

21.31

21.49

0.67

2676

8499

(3052851) Hemolysis interference index of Serum or Plasma

2507

7228

2.08

218.45

3.2

3.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2288

6396

2.14

215.61

1.5

1.4

18.66

11.89

iu/ml

0.99

149

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2286

6399

2.14

214.69

3.3

3.4

41.00

47.07

mg/l

0.78

1885

5111

(3034860) Kappa light chains.free [Mass/volume] in Serum

2288

6419

2.13

213.66

3.4

76.08

63.36

mg/l

0.21

1881

5124

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3655

12153

1.81

210.58

9.1

9.9

24.27

mmol/l

0.03

3531

11717

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2227

6234

2.14

209.05

3.3

3.4

2.80

5.70

ratio

0.96

221

454

(3022621) pH of Urine by Test strip

4515

16031

1.70

207.69

3.3

2.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

894

1570

3.37

204.81

1.4

128781.96

100083.90

e6/l

0.50

622

1049

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1988

5359

2.21

204.51

1.4

1.3

3.73

3.71

mmol/l

0.29

1866

5033

(3003327) Ova and parasites identified in Stool by Light microscopy

2859

8862

1.93

203.98

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

937

1705

3.26

203.49

1.5

30.42

32.59

0.86

581

1098

(3000492) Spirometry study

6588

25893

1.55

201.44

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2213

6297

2.10

199.18

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5092

18951

1.63

195.35

3.0

2.5

67.02

68.10

ml/min/173m2

0.96

2160

7230

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2542

7723

1.97

191.80

1.6

10.85

3.84

iu/ml

0.59

552

1591

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1964

5411

2.16

191.54

1.5

1368.90

2348.79

e6/l

0.55

1619

4370

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1963

5408

2.16

191.46

1.5

23.55

30.83

e6/l

0.42

1540

4155

(3017143) Hepatitis C virus Ab [Presence] in Serum

8566

35949

1.46

190.70

1.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

4754

17540

1.64

188.40

2.8

2.7

4.94

4.87

e9/l

0.11

3813

14419

(3007930) Methemoglobin/Hemoglobin.total in Blood

2818

8967

1.88

185.65

4.9

5.2

0.89

0.08

2657

8405

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1789

4826

2.21

183.50

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3176

10566

1.80

181.87

1.1

2.94

11.11

u/ml

1.38

160

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8575

36291

1.45

181.84

1.9

1.7

1.51

1.40

31.29

7457

32433

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2847

9157

1.86

181.42

4.9

5.1

1.75

1.68

1.72

2683

8584

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2274

6770

2.01

181.33

1.9

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2736

8696

1.88

180.77

2.1

2.0

2.10

2.50

ug/l

0.71

2392

7656

(3022313) Gas panel - Capillary blood

3224

10851

1.78

177.58

4.0

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2904

9525

1.83

173.88

4.1

4.3

24.68

24.69

mmol/l

0.06

2707

8864

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1813

5049

2.14

171.97

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1836

5141

2.13

171.79

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1813

5053

2.14

171.63

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2121

6292

2.01

170.64

2.0

2.1

10.79

10.82

mg/l

0.06

1963

5908

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2624

8407

1.87

168.97

2.6

94.42

91.66

7.58

2504

8070

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

16190

76825

1.32

168.69

4.9

4.6

2.76

3.46

ug/l

2.45

14582

68952

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2970

9908

1.80

168.21

2.2

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2406

7504

1.92

167.95

3.6

3.3

0.33

0.35

u/ml

1.31

1409

4176

(40760888) Immunoglobulin light chains.free panel - Serum

1734

4792

2.15

167.60

3.1

3.6

—

(3014051) Protein [Presence] in Urine by Test strip

2009

5921

2.02

164.43

2.6

2.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2985

10059

1.78

163.39

4.9

3.8

48.80

48.38

0.38

2959

9940

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2428

7666

1.89

163.34

3.0

2.6

181.48

184.28

0.79

2288

7298

(3039162) Centromere protein B Ab [Units/volume] in Serum

1176

2787

2.50

160.27

1.3

1.2

39.65

59.12

u/ml

1.72

157

(3038026) Centromere Ab [Units/volume] in Serum

811

1585

3.03

157.23

1.2

65.23

45.58

u/ml

0.55

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6952

28990

1.46

157.18

4.6

4.0

31.71

32.15

2.63

5150

20242

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2785

9308

1.79

156.52

1.6

1.7

—

(40768443) Skin Pathology biopsy report

3033

10398

1.75

156.43

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2722

9036

1.80

156.42

2.0

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1593

4376

2.16

156.17

1.3

1.2

75.17

125.62

titre

1.02

(3047181) Lactate [Moles/volume] in Blood

2288

7221

1.89

153.96

5.3

5.9

1.28

1.32

mmol/l

1.04

2046

6382

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

794

1552

3.02

153.90

1.2

52.67

40.70

u/ml

0.63

116

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1174

2841

2.45

153.24

6.8

6.1

11.58

11.22

mg/l

1.62

1085

2614

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

791

1548

3.02

153.01

1.2

88.14

56.49

u/ml

1.86

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3578

12921

1.66

152.76

3.0

2.6

0.23

0.31

e6/l

3.24

3472

12552

(3049717) Cytology report of Urine Cyto stain

2508

8195

1.83

151.55

2.4

2.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

769

1491

3.05

151.05

1.2

3.28

14.90

u/ml

2.66

110

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1329

3439

2.29

149.95

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

554

875

3.73

147.40

1.1

—

(3003338) MCHC [Mass/volume]

45259

246780

1.30

147.39

24.7

14.9

332.12

332.92

g/l

62.51

45005

244554

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4942

19494

1.53

145.74

1.2

121.57

147.20

iu/ml

4.45

1703

7460

(3027273) Bicarbonate [Moles/volume] in Venous blood

3136

11071

1.70

145.49

4.3

3.3

25.38

25.13

mmol/l

3.73

3054

10718

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1958

5980

1.95

144.94

3.1

3.2

24.67

24.52

mmol/l

0.82

1925

5830

(3000330) Specific gravity of Urine by Test strip

3258

11675

1.67

142.93

3.9

3.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3580

13177

1.63

141.60

1.1

114.04

210.63

titre

1.96

393

(3002256) Pathology report gross observation

7780

33704

1.40

141.60

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2261

7319

1.84

140.56

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2265

7355

1.84

139.40

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2239

7251

1.84

138.97

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2152

6897

1.86

137.96

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1425

3944

2.14

137.02

1.3

1.2

3.81

4.03

u/ml

0.26

636

1792

(3018405) Lactate [Moles/volume] in Arterial blood

2330

7711

1.80

134.87

4.4

4.1

1.32

1.42

mmol/l

3.86

2286

7578

(3024928) Oxygen saturation in Venous blood

1642

4855

2.01

132.94

4.6

3.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1405

3914

2.13

132.91

1.5

1.6

0.70

0.80

g/l

2.19

1072

2938

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1712

5152

1.97

132.01

1.4

1.3

—

(3010421) pH of Blood

2027

6483

1.86

130.69

4.3

3.8

7.42

0.20

1859

5913

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

892

2047

2.58

129.60

1.2

1.1

38.17

44.90

mg/l

1.64

763

1679

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3855

14749

1.57

129.54

1.1

1.0

—

(3024263) Appearance of Synovial fluid

528

886

3.51

129.27

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

633

1199

3.12

129.15

1.1

3.35

6.64

nmol/l

0.96

103

251

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1031

2552

2.39

128.25

1.1

51.88

60.06

au/ml

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1043

2604

2.37

127.35

1.1

40.17

21.67

au/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1386

3910

2.10

126.98

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2253

7518

1.79

126.80

1.4

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1024

2552

2.37

125.52

1.5

1.6

25.54

36.13

iu/ml

1.42

130

(1616796) Gas panel - Central venous blood

1784

5546

1.91

125.25

3.7

3.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

860

1972

2.58

125.15

1.1

251.37

264.80

mg/l

0.49

771

1716

(3023511) Choriogonadotropin [Units/volume] in Urine

2173

7201

1.80

125.09

1.5

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2392

8169

1.75

124.43

3.1

2.7

3.60

3.59

g/l

0.13

2274

7796

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2206

7363

1.78

124.01

2.8

2.6

—

(3037756) Immunofixation for Serum or Plasma

1472

4292

2.03

123.70

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

1689

5179

1.94

123.41

2.7

2.4

16.46

16.63

0.80

904

2635

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

780

1730

2.66

121.02

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1334

3778

2.09

120.98

1.1

120.67

116.42

4.41

1203

3429

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

781

1734

2.66

120.94

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

780

1732

2.66

120.76

1.2

1.1

—

(3012501) Base excess in Blood by calculation

1794

5670

1.88

119.83

4.3

3.9

2.33

2.50

mmol/l

1.57

1214

3720

(3013290) Carbon dioxide [Partial pressure] in Blood

1794

5672

1.88

119.70

4.3

3.9

5.02

4.99

kpa

0.65

1760

5519

(3027315) Oxygen [Partial pressure] in Blood

1801

5704

1.88

119.54

4.3

3.9

8.70

kpa

0.02

1767

5550

(3028707) Methadone [Presence] in Urine by Screen method

1871

6003

1.85

119.34

3.6

2.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

772

1721

2.65

118.64

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

770

1717

2.65

118.27

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1411

4124

2.03

117.79

1.3

1.2

3.80

3.87

u/ml

0.04

463

1483

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

770

1721

2.64

117.75

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1085

2873

2.24

116.02

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

2091

7015

1.77

115.44

1.2

1.3

112.02

120.92

titre

0.20

213

644

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

773

1751

2.61

115.21

1.2

1.1

54.83

77.97

u/ml

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1054

2767

2.25

114.98

1.4

—

(3020891) Body temperature

2517

8916

1.68

114.71

5.6

4.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1052

2764

2.25

114.55

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6676

29146

1.38

113.99

7.7

6.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

502

892

3.32

113.12

1.5

1.4

5.55

4.15

0.71

104

223

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1049

2769

2.24

112.99

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1056

2808

2.22

111.80

1.4

—

(40761536) Microorganisms panel - Urine sediment

5555

23593

1.42

111.07

4.9

3.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1055

2813

2.22

110.98

1.4

—

(4062490) Immunoglobulin typing, IgG

956

2447

2.31

110.49

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

925

2339

2.34

109.84

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

815

1943

2.48

109.71

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

2027

6853

1.76

108.95

1.2

1.3

927.25

890.97

titre

0.07

186

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12654

60902

1.28

108.84

4.3

4.0

21.93

22.01

0.19

5712

28217

(3024139) IgG subclass 3 [Mass/volume] in Serum

949

2440

2.30

108.58

1.4

1.3

0.38

0.40

g/l

1.21

689

1673

(3027135) IgG subclass 1 [Mass/volume] in Serum

950

2446

2.30

108.35

1.4

1.3

6.43

6.96

g/l

4.05

686

1674

(3028192) IgG subclass 2 [Mass/volume] in Serum

948

2443

2.29

107.91

1.4

1.3

2.90

2.97

g/l

0.52

688

1674

(3043409) Potassium [Moles/volume] in Arterial blood

1967

6623

1.77

107.18

4.7

4.4

3.87

3.88

mmol/l

0.60

1949

6564

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1136

3186

2.11

105.59

1.2

1.3

0.26

0.23

nmol/l

0.15

186

(3028271) Lactate [Moles/volume] in Capillary blood

1302

3849

2.00

105.34

2.0

1.8

1.69

1.79

mmol/l

2.85

1282

3755

(3037121) Protein [Mass/volume] in Urine

2366

8437

1.67

105.03

3.1

3.4

0.34

0.31

g/l

0.51

982

4086

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1132

3200

2.09

103.11

1.2

1.3

1.09

1.03

nmol/l

0.04

1096

3082

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1718

5627

1.81

102.52

1.6

—

(3021901) Oxygen saturation in Capillary blood

1430

4434

1.91

101.02

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5348

22994

1.40

99.03

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

693

1605

2.55

98.94

1.6

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1574

5079

1.84

98.47

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1038

2898

2.12

97.59

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3668

14763

1.49

96.62

2.5

2.3

6088.06

6389.03

u/l

0.21

1252

6112

(3018572) Chloride [Moles/volume] in Blood

1524

4912

1.84

95.68

6.2

7.1

104.77

105.30

mmol/l

3.77

1384

4414

(3039000) Anion gap in Blood

1523

4912

1.84

95.41

6.2

7.1

11.13

11.29

mmol/l

0.99

1383

4413

(3023410) Appearance of Cerebral spinal fluid

939

2543

2.18

95.18

1.8

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1864

6402

1.73

94.74

3.5

4.1

8.45

8.53

kpa

1.22

1831

6233

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1687

5637

1.78

94.21

2.2

2.1

129.97

131.22

g/l

1.08

1271

4170

(3016018) Differential panel - Cerebral spinal fluid

985

2738

2.13

93.64

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1313

4062

1.91

93.36

1.9

4.86

5.31

mmol/24h

4.49

1153

3616

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1163

3452

1.99

93.04

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

968

2695

2.12

91.66

2.4

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1635

5463

1.77

91.31

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

992

2793

2.10

91.30

1.2

1.1

96.12

95.13

0.50

924

2623

(3023183) Ammonium ion [Moles/volume] in Plasma

1571

5205

1.79

90.22

3.2

2.7

33.16

34.30

umol/l

0.75

1428

4701

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

657

1573

2.46

87.74

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

655

1566

2.47

87.73

1.2

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1070

3149

2.01

87.63

2.0

1.8

90.15

89.86

0.83

1054

3095

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

594

1361

2.57

86.68

1.1

1.06

1.08

u/l

0.19

263

609

(21494755) Public health laboratory ask at order entry panel

4312

34207

0.72

86.13

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1347

4319

1.85

85.92

1.4

1.3

22.75

23.56

u/l

0.40

1082

3618

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

913

2559

2.11

85.01

1.2

28.17

28.94

nmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3616

14904

1.45

84.01

1.4

25.84

25.37

iu/l

0.36

3059

12713

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4732

20484

1.38

83.41

2.4

2.1

11.69

12.11

nmol/l

2.64

4190

18490

(3023419) Bacteria identified in Sputum by Culture

1049

3124

1.98

83.16

2.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1340

4346

1.82

82.44

3.6

3.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5447

24181

1.35

81.92

3.6

4.2

11.92

28.48

ug/l

6.56

4302

19312

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

502

1088

2.72

81.46

2.3

2.1

116.86

155.17

umol/l

1.91

264

524

(42529582) MDA5 Ab [Presence] in Serum by Line blot

282

422

3.93

80.76

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

282

422

3.93

80.76

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

282

422

3.93

80.76

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

282

422

3.93

80.76

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2101

7768

1.61

80.64

1.1

4.09

5.59

u/ml

0.79

215

1150

(3048929) Epstein Barr virus Ab [Presence] in Serum

2596

10100

1.53

79.94

1.3

—

(3045424) Erythrocytes [Presence] in Urine

1271

4096

1.84

79.79

1.5

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1148

3587

1.89

79.25

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3580

14892

1.43

79.04

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1534

5266

1.73

78.01

6.1

5.8

4267.09

1053.81

iu/ml

0.58

227

755

(3044927) Protein electrophoresis panel - Urine

709

1869

2.24

76.69

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1195

3836

1.84

75.95

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1195

3838

1.84

75.83

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1188

3813

1.84

75.54

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1977

7322

1.60

75.30

1.2

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1230

4025

1.81

73.53

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1240

4076

1.80

73.05

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8371

40016

1.26

72.07

2.2

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

896

2656

1.99

71.98

2.3

1.9

20.02

28.78

mg/l

4.89

242

679

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

405

844

2.82

70.62

1.2

0.31

0.30

g/l

1.99

324

670

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

711

1945

2.16

70.41

1.2

1.3

1.92

2.10

mmol/l

3.73

664

1803

(3035637) Corticotropin [Mass/volume] in Plasma

1019

3185

1.89

70.29

1.5

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

294

507

3.41

69.47

1.3

55.54

53.83

0.28

251

439

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

384

784

2.88

69.41

1.2

112.65

109.97

1.03

337

709

(46235355) HIV 1 and 2 tests - Meaningful Use set

12962

65172

1.21

69.22

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9141

44358

1.24

68.67

3.1

2.8

0.71

0.79

ug/l

8.66

6188

27942

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6866

32214

1.28

68.59

1.7

1.8

—

(3011985) Renin [Units/volume] in Plasma

1024

3233

1.87

68.53

1.5

1.6

68.64

64.26

mu/l

0.26

921

2909

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

938

2876

1.93

68.50

1.1

1.62

2.15

iu/ml

0.32

(3036670) Protein [Mass/volume] in Synovial fluid

284

483

3.46

68.48

1.3

1.2

39.82

40.11

g/l

0.10

170

264

(3035947) Staphylolysin Ab [Units/volume] in Serum

470

1079

2.56

68.44

1.1

3.97

4.18

iu/ml

0.11

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10772

53232

1.23

68.23

1.7

—

(3036180) Methadone [Presence] in Urine

593

1523

2.29

68.16

2.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

496

1175

2.49

67.82

1.3

1.2

282.76

298.74

u/l

0.11

460

1103

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

809

2377

2.01

66.62

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2440

9733

1.49

66.58

2.0

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1158

3839

1.78

66.35

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

9115

44371

1.24

66.28

2.3

2.2

—

(3011288) Drugs identified in Urine by Screen method

2465

9868

1.48

66.08

4.3

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1409

4967

1.68

65.06

1.6

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

740

2132

2.05

64.25

1.8

1.4

1.50

1.35

promille

1.67

562

1630

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1124

3732

1.78

64.08

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

950

2998

1.87

63.68

1.3

1.4

361.84

360.89

pmol/l

0.01

814

2632

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1076

3545

1.79

62.94

1.3

30.13

36.34

u/l

0.92

947

3068

(21494890) Protein electrophoresis panel - 24 hour Urine

735

2129

2.04

62.92

2.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1177

3989

1.74

62.59

3.2

4405.34

6685.69

u/ml

0.19

231

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1752

6595

1.57

62.26

1.8

1.9

8.97

21.37

iu/l

0.63

596

2501

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

800

2405

1.96

61.85

1.2

61.10

68.75

u/l

1.40

726

2155

(3017354) Segmented neutrophils/100 leukocytes in Blood

751

2208

2.01

61.77

3.1

3.2

57.51

57.04

0.23

637

1850

(3004809) Band form neutrophils/100 leukocytes in Blood

1135

3825

1.75

61.55

3.1

3.2

1.38

1.58

1.08

1013

3388

(3019420) Tryptase [Mass/volume] in Serum or Plasma

517

1309

2.33

61.41

1.5

1.6

8.82

8.07

ug/l

0.26

466

1180

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1037

3405

1.80

61.34

1.4

—

(3003181) Sodium [Moles/volume] in Urine

1135

3862

1.74

59.54

1.4

1.5

62.62

64.04

mmol/l

0.50

925

3009

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

253

441

3.37

58.94

1.3

38.80

39.01

0.02

169

303

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

693

2013

2.03

58.91

3.6

3.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

384

859

2.63

58.89

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1154

3958

1.72

58.87

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

542

1429

2.23

58.73

1.5

24.76

24.42

u/ml

0.05

292

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1599

5975

1.58

58.62

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

347

739

2.76

58.32

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

359

779

2.71

58.30

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2721

11392

1.42

57.54

3.1

2.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1566

5855

1.58

57.27

1.5

1.4

19.29

19.79

u/ml

0.04

106

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1573

5890

1.58

57.16

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2346

9571

1.45

57.03

1.4

10.35

9.16

u/l

3.52

1902

7762

(21491868) Cryoglobulin [Mass/volume] in Serum

351

764

2.70

56.70

1.2

0.87

0.46

g/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

513

1350

2.24

55.86

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

622

1770

2.07

55.86

1.3

1.77

2.42

u/ml

0.73

373

962

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

954

3160

1.78

54.87

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

477

1226

2.29

54.85

1.2

22.85

9.08

u/ml

0.74

124

(3020876) Protein [Mass/time] in 24 hour Urine

788

2457

1.89

54.84

2.6

1.31

1.34

g/24h

0.10

393

1284

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1502

5625

1.58

54.54

1.3

270.66

253.70

u/ml

1.31

977

3610

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

13.20

54.53

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1202

4265

1.66

54.18

1.1

17.07

11.53

au/ml

0.90

297

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

903

2959

1.80

53.82

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

211

347

3.57

53.49

1.0

—

(3003694) ABO and Rh group [Type] in Blood

16166

84385

1.17

53.28

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

977

3291

1.75

53.11

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

797

2525

1.86

52.86

3.5

3.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2873

12332

1.38

52.49

1.7

1.6

304.11

317.16

mu/l

0.97

2588

11075

(4094501) Cardiovascular stress test using bicycle ergometer

1592

6143

1.53

50.71

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

467

1232

2.23

50.62

2.0

1.7

143.65

140.02

0.40

447

1160

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

783

2502

1.84

50.60

1.6

1.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

333

750

2.61

50.50

2.4

2.1

64.86

62.85

ug/l

0.15

324

733

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

515

1419

2.14

50.27

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1363

5094

1.58

49.94

4.0

2.9

1.49

1.61

mmol/l

4.56

1336

4992

(3017817) Protein [Mass] in Urine collected for unspecified duration

662

2010

1.94

49.86

2.4

2.6

0.11

0.86

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

629

1876

1.97

49.83

1.2

1.3

—

49.07

u/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1829

7309

1.48

49.34

4.9

4.4

1.61

1.44

mg/l

12.74

1688

6790

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

491

1339

2.16

49.17

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

834

2744

1.79

49.09

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1139

4092

1.64

48.98

5.3

5.2

354.30

373.52

umol/l

3.85

976

3588

(3042631) Mycobacterium sp identified in Specimen

889

2987

1.76

48.78

2.5

2.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

495

1362

2.14

48.50

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

477

1293

2.17

48.49

2.3

2.6

944.00

1062.52

u/ml

0.37

471

1275

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1440

5492

1.55

48.33

1.5

111.15

110.29

u/ml

0.07

325

1161

(4034850) Laboratory test

1929

7823

1.46

48.30

9.9

9.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

812

2664

1.80

48.25

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

812

2665

1.80

48.19

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9561

48125

1.19

47.77

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

561

1630

2.03

47.77

1.1

1.06

1.07

ratio

0.57

191

610

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

630

1909

1.94

47.75

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

630

1909

1.94

47.75

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

630

1909

1.94

47.75

1.6

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

377

930

2.38

47.55

1.1

548.97

442.79

ng/l

0.13

226

(3035320) C reactive protein [Mass/volume] in Body fluid

594

1766

1.98

47.50

2.7

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

450

1203

2.20

47.31

1.4

1.2

54.59

96.99

titre

1.25

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

460

1245

2.17

46.95

1.4

1.2

589.63

318.20

titre

0.67

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

498

1392

2.11

46.93

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

306

686

2.62

46.87

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

119

136

5.14

46.51

1.3

1.2

5.71

6.62

mmol/l

0.65

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1447

5574

1.53

46.45

2.0

1.8

183.36

194.77

pmol/l

3.63

1359

5328

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

679

2131

1.88

46.42

2.8

2.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

974

3416

1.68

45.91

1.1

1.51

1.50

g/l

0.36

865

3112

(1002224) Polysomnography panel

2651

11484

1.37

45.69

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

710

2275

1.84

45.54

1.6

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

783

2587

1.78

45.49

3.6

3.3

—

(3000012) Reticulocyte production index

929

3225

1.70

45.47

2.1

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1671

6666

1.48

45.46

1.2

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1204

4473

1.59

45.25

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

301

683

2.59

45.06

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

663

2085

1.87

45.06

1.2

190.17

195.17

titre

0.05

119

348

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2330

9910

1.39

44.87

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

862

2945

1.73

44.68

2.0

2.2

32.50

32.67

0.51

853

2925

(3038515) Glucose [Moles/volume] in Venous blood

1272

4803

1.56

44.62

4.1

3.0

7.37

7.61

mmol/l

2.14

1248

4723

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

660

2080

1.87

44.57

1.2

69.29

204.94

titre

2.40

(3002619) Bacteria identified in Specimen by Culture

222

430

3.03

44.08

1.4

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2765

21322

0.75

44.02

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

709

2297

1.82

43.93

1.9

2.5

19.02

20.26

nmol/l

2.44

662

2192

(40757494) Bilirubin.total [Moles/volume] in Blood

413

1104

2.20

43.48

2.2

2.3

28.84

51.46

umol/l

1.48

123

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

814

2760

1.74

43.34

1.7

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1217

4585

1.57

43.12

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4077

29814

0.79

43.00

1.7

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

809

2752

1.73

42.60

1.1

—

(3008295) Osmolality of Serum or Plasma

716

2350

1.79

42.55

1.5

1.6

281.62

279.82

mosm/kgh2o

1.24

540

1859

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1015

3687

1.62

41.84

1.7

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

409

1122

2.14

40.48

1.5

1.7

3.42

10.53

nmol/l

0.77

335

940

(3045716) Anion gap in Serum or Plasma

372

983

2.22

40.30

2.7

2.3

9.49

9.96

mmol/l

1.76

360

961

(3000093) Morphology [Interpretation] in Blood Narrative

697

2310

1.78

40.15

1.2

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

354

918

2.27

40.07

2.0

1.7

157.08

165.42

0.72

332

867

(4035726) Immunohistochemistry procedure

4661

22196

1.25

39.78

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

596

1893

1.85

39.37

1.1

294.21

289.71

mg/l

0.60

527

1718

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

210

422

2.92

39.28

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

378

1021

2.18

38.89

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

378

1022

2.17

38.80

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

255

577

2.60

38.48

1.3

141.57

127.14

nmol/l

0.42

186

437

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

196

383

3.01

38.44

1.3

1.2

39.65

49.04

mg/l

0.12

149

281

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

578

1833

1.86

38.38

1.9

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

461

1357

2.00

38.02

1.2

90.19

94.50

u/l

0.38

402

1195

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

408

1150

2.09

37.76

1.1

7.64

11.16

u/ml

1.05

212

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2672

20269

0.76

37.54

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

407

1150

2.08

37.44

1.1

98.48

96.36

0.64

322

913

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

632

2078

1.79

37.41

1.4

1.3

1.52

1.41

nmol/l

1.53

565

1889

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

323

830

2.29

37.37

2.7

2.1

—

(3016879) Cocaine [Presence] in Urine

3029

13788

1.30

37.17

3.0

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1296

5117

1.49

37.12

2.6

2.0

0.91

0.82

nmol/l

3.56

1081

4349

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

500

1534

1.92

36.70

2.6

3.6

106.77

136.98

nmol/l

1.31

489

1504

(3017704) Immunofixation for Urine

394

1108

2.09

36.70

1.5

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

447

1320

1.99

36.57

1.2

26.80

23.93

u/l

0.48

381

1144

(3004451) EKG impression Narrative

368

1011

2.14

36.36

1.3

—

(3011412) CD3 cells [#/volume] in Blood

743

2584

1.69

36.23

2.4

2.5

1.30

1.23

e9/l

0.77

660

2277

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1958

8390

1.38

36.03

1.9

1.7

39.97

41.43

nmol/l

1.63

1905

8222

(3019977) pH of Arterial blood

425

1239

2.02

36.02

2.5

7.42

0.39

133

428

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

551

1759

1.84

35.88

1.9

3.48

3.82

mg/l

1.00

525

1670

(3000034) Microalbumin [Mass/volume] in Urine

621

2059

1.78

35.78

2.9

3.0

62.43

52.83

mg/l

0.30

432

1482

(3002079) Sodium [Moles/time] in 24 hour Urine

404

1164

2.04

35.35

1.3

1.2

155.01

159.89

mmol/24h

0.48

404

1164

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

533

1694

1.85

35.20

2.4

2.3

100.55

96.49

1.96

502

1588

(3042517) Benzodiazepines panel - Urine

182

359

2.98

35.19

2.9

3.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

352

966

2.14

34.90

2.8

2.9

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

247

581

2.50

34.58

1.1

6.63

6.83

mg/g

0.12

233

557

(3026470) Cobalt [Mass/volume] in Blood

390

1119

2.05

34.52

2.0

3.91

3.69

ug/l

0.14

357

1019

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

323

862

2.20

34.28

1.2

1.1

92.66

90.06

0.49

157

405

(3000764) Benzodiazepines [Presence] in Urine

3200

14835

1.28

34.07

2.9

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

580

1915

1.78

33.92

1.3

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

424

1264

1.97

33.84

1.6

22.21

25.13

umol/l

1.18

408

1207

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

419

1249

1.97

33.45

1.2

1.3

65.32

63.38

0.13

150

(3028300) Cannabinoids [Presence] in Urine

3216

14962

1.27

33.26

2.9

2.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2967

13665

1.29

33.25

2.8

3.2

51.99

49.75

u/ml

0.07

2853

13219

(1761482) Bacteria [#/volume] in Urine by Culture

1488

6169

1.42

33.16

5.2

3.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

346

963

2.11

33.15

2.5

2.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

642

2203

1.72

32.91

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

525

1702

1.81

32.62

1.1

8.93

7.70

iu/ml

0.42

126

439

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

328

900

2.14

32.58

1.2

1.1

112.02

105.81

1.82

305

817

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

325

889

2.15

32.53

1.1

90.74

90.31

0.08

156

415

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

456

1415

1.90

32.44

1.6

1.5

7.86

6.25

u/l

1.37

372

1107

(4146454) Self-monitoring of blood glucose

660

2295

1.69

32.27

2.8

2.7

—

(3027008) Opiates [Presence] in Urine

3199

14940

1.27

32.05

2.9

2.0

—

(3051651) Icteric interference index of Serum or Plasma

492

1572

1.84

32.02

4.0

3.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

459

1438

1.88

31.75

1.4

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

770

2806

1.62

31.47

2.8

2.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1942

8498

1.35

31.33

3.1

3.6

488.51

1271.41

u/ml

2.91

1644

7320

(3025577) Chromium [Mass/volume] in Blood

372

1089

2.01

31.27

2.1

2.0

2.32

2.33

ug/l

0.01

305

909

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

571

1928

1.74

31.01

2.3

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

559

1880

1.75

30.78

2.4

2.6

532.48

550.84

e6/l

0.26

468

1541

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

107

161

3.90

30.77

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

360

1048

2.02

30.73

2.1

2.3

165.78

200.81

ug/l

0.10

347

988

(3027923) C peptide [Moles/volume] in Serum or Plasma

406

1237

1.93

30.52

1.6

1.12

1.29

nmol/l

2.65

309

986

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1152

4623

1.47

30.52

1.6

1.5

—

(21494434) Karyotype in Bone marrow

568

1926

1.73

30.41

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

314

871

2.12

30.40

1.1

—

(44813793) Dust mix specific IgE antibody measurement

554

1867

1.75

30.31

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

358

1046

2.01

30.27

2.3

2.0

111.00

101.30

ug/min

0.10

238

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

543

1824

1.75

30.04

2.4

2.7

0.23

e9/l

0.08

467

1539

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

734

2677

1.61

29.93

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

560

1901

1.73

29.88

3.3

28.70

26.32

mu/l

0.67

530

1784

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1054

4175

1.49

29.80

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

710

2576

1.62

29.57

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

320

905

2.08

29.51

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

361

1070

1.98

29.36

1.9

2.1

28.85

28.28

umol/l

0.51

351

1035

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1018

4018

1.49

29.30

3.3

3.1

0.81

nmol/l

0.01

771

3096

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

391

1194

1.92

29.23

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

390

1195

1.92

28.87

1.7

1.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1126

9366

0.70

28.86

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

509

1699

1.76

28.80

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1098

9162

0.70

28.65

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

770

2873

1.58

28.60

5.5

9.3

7.40

7.33

mmol/l

0.12

650

2347

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

373

1133

1.93

28.33

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

555

1909

1.71

28.30

1.4

12.06

12.02

umol/l

0.05

531

1806

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

544

1862

1.72

28.23

1.5

—

(3036603) Volume of Urine

489

1624

1.77

28.16

1.7

1.6

2007.35

1986.56

0.17

474

1584

(3005033) Fetal Nuchal fold Thickness US

1100

9146

0.70

28.13

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1357

5713

1.40

27.78

1.8

1.7

—

(3047189) Immunofixation for 24 hour Urine

323

941

2.02

27.58

1.9

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1327

5573

1.40

27.56

2.4

2.3

133.85

103.77

ug/min

1.45

776

3351

(3027944) Amphetamines [Presence] in Urine

3103

14706

1.25

27.36

2.8

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

183

418

2.57

27.30

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

238

616

2.27

27.27

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

239

621

2.26

27.14

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

275

760

2.13

26.95

1.2

1.3

16.81

20.63

0.38

128

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

378

1174

1.89

26.94

1.2

1.1

24.55

23.80

u/l

0.09

350

1053

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

378

1174

1.89

26.94

1.2

1.1

82.86

84.90

u/l

0.17

352

1055

(3007916) DNA double strand Ab [Titer] in Serum

130

247

3.09

26.86

1.3

1.4

78.22

203.17

titre

—

(1175426) CD3 cells/100 lymphocytes in Blood

592

2107

1.65

26.64

2.2

2.1

74.18

72.03

2.82

565

2033

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

253

681

2.18

26.46

2.6

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

253

681

2.18

26.46

2.6

2.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1131

4651

1.43

26.43

3.0

3.5

1206.11

709.76

u/ml

0.37

1018

4229

(3017569) Oxygen content in Arterial blood

331

989

1.97

26.40

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

235

614

2.25

26.37

1.1

—

(3034426) Prothrombin time (PT)

303

877

2.03

26.36

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1123

4621

1.43

26.16

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

224

577

2.28

25.98

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2252

10339

1.29

25.84

1.3

216.47

227.52

miu/ml

0.72

976

4926

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

581

2077

1.65

25.72

2.2

2.1

13.96

14.70

0.88

563

2027

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

299

871

2.02

25.59

1.4

14.69

14.76

pmol/l

0.04

255

740

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

367

1151

1.87

25.43

1.5

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

235

624

2.21

25.41

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

367

1152

1.87

25.37

1.5

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

335

1021

1.93

25.27

3.4

4.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2408

11180

1.27

25.27

2.1

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1047

4283

1.44

25.19

2.0

2.2

3.85

7.07

titre

0.99

138

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1473

6390

1.36

25.18

1.1

1.80

2.45

u/ml

1.58

787

3306

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

479

1638

1.72

25.01

1.8

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

369

1167

1.86

24.94

38.4

36.6

7.36

7.30

ug/l

0.17

343

1059

(3013005) Retinol [Moles/volume] in Serum or Plasma

369

1171

1.85

24.68

1.9

2.1

1.96

1.92

umol/l

0.35

344

1114

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

355

1113

1.87

24.65

2.5

52.98

51.99

umol/l

0.22

309

979

(3050129) First trimester maternal screen panel - Serum or Plasma

1882

14155

0.77

24.58

1.5

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

208

536

2.28

24.14

1.1

1.2

257.14

547.14

titre

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1551

11922

0.76

23.89

1.5

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

519

1838

1.66

23.87

11.9

12.4

0.60

0.62

mmol/l

1.56

474

1687

(3033923) Metanephrine [Moles/time] in 24 hour Urine

180

437

2.42

23.81

1.1

0.67

4.09

umol/24h

0.53

218

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1414

6159

1.35

23.57

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1038

4295

1.42

23.51

1.1

9417.00

801.05

iu/ml

0.50

258

1002

(3012565) Volume of 24 hour Urine

381

1242

1.80

23.44

2.1

2.2

1906.21

1996.81

0.84

337

1113

(3001186) Copper [Moles/volume] in Serum or Plasma

222

596

2.19

23.44

1.4

17.09

16.98

umol/l

0.11

193

532

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4181

20761

1.19

23.15

2.0

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

218

584

2.19

23.14

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

322

999

1.89

23.11

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

715

2759

1.52

23.01

2.9

3.4

4.45

8.40

nmol/l

1.19

692

2684

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1450

11185

0.75

22.92

1.4

—

(3006270) Folate [Moles/volume] in Blood

553

2012

1.62

22.91

1.2

1.1

358.80

376.38

nmol/l

1.12

460

1709

(3001964) Herpes simplex virus Ag [Presence] in Specimen

266

774

2.02

22.90

1.7

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

222

602

2.17

22.89

1.2

1.3

109.59

104.77

1.15

213

564

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

402

1343

1.76

22.82

1.7

1.6

2330330.47

1595350.61

iu/ml

0.42

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1450

11177

0.75

22.80

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

214

573

2.19

22.76

1.3

1.1

89.42

87.19

0.19

143

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

604

5398

0.65

22.67

1.2

—

(3007463) Buprenorphine [Presence] in Urine

109

4.04

22.65

8.0

8.2

—

(3011048) Pyruvate [Moles/volume] in Blood

148

3.53

22.53

1.5

1.3

78.82

84.67

umol/l

0.69

134

(3010375) cycloSPORINE [Mass/volume] in Blood

363

1181

1.81

22.50

30.0

27.4

115.39

120.96

ug/l

0.71

297

990

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1445

11120

0.76

22.45

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

408

1376

1.74

22.43

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

275

818

1.97

22.31

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

154

359

2.52

22.18

1.1

—

(3020491) Glucose [Moles/volume] in Blood

532

1937

1.61

22.01

1.7

1.8

6.95

6.56

mmol/l

1.77

387

1457

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

466

1640

1.67

22.00

1.5

1.4

12.80

12.63

u/l

0.18

445

1589

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

212

574

2.17

21.97

1.2

1.1

76.16

75.24

0.06

139

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1455

11149

0.76

21.91

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

328

1043

1.85

21.88

2.0

1.9

—

(3045142) Bone marrow Pathology biopsy report

664

2556

1.53

21.65

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

196

518

2.22

21.53

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

158

379

2.45

21.49

1.3

16.11

242.62

titre

2.17

(3014271) Vancomycin [Susceptibility]

339

1098

1.81

21.35

3.3

2.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

416

1432

1.71

21.32

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

753

2988

1.48

21.26

1.5

1.4

32.08

33.46

g/l

2.05

675

2673

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1016

4266

1.40

21.23

1.1

2.23

2.95

u/ml

1.79

402

2183

(3006922) Hepatitis E virus Ab [Presence] in Serum

522

1909

1.61

21.23

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

182

470

2.27

21.10

1.5

1.6

0.43

0.42

ug/l

0.07

132

300

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1265

9818

0.75

20.91

1.7

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

345

1131

1.79

20.91

2.4

10.32

11.51

0.90

322

1062

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

472

1693

1.64

20.75

1.2

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.74

20.65

1.5

1.6

270.67

241.11

nmol/l

0.13

(40768446) Kidney Pathology biopsy report

321

1035

1.82

20.54

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

802

1.94

20.53

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

686

2691

1.50

20.51

1.5

1.4

2818.71

3076.96

e6/l

0.19

483

1936

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

157

385

2.39

20.42

1.7

3.0

1.19

1.20

mmol/l

0.37

152

364

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

878

3620

1.43

20.35

1.7

1.9

2702.86

4018.60

titre

0.52

172

(3051593) INR in Capillary blood by Coagulation assay

314

1009

1.83

20.32

8.6

10.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

123

269

2.68

20.09

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1304

5754

1.34

20.02

1.1

5.57

5.96

u/ml

0.32

703

3073

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1029

8176

0.73

19.99

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

152

371

2.40

19.98

1.1

1.0

0.47

0.20

u/ml

0.37

223

(3022493) Free Hemoglobin [Mass/volume] in Plasma

330

1085

1.79

19.84

5.7

4.9

1941.64

2573.90

mg/l

0.21

238

785

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

295

938

1.85

19.75

2.0

2.1

8.86

9.54

mg/l

1.18

233

756

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5116

26167

1.16

19.64

2.1

2.0

—

(3016038) Potassium [Moles/volume] in Urine

430

1530

1.65

19.54

1.3

1.4

32.83

34.36

mmol/l

0.62

365

1330

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

136

318

2.51

19.54

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

287

908

1.86

19.52

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

331

1097

1.77

19.40

2.3

2.2

28.26

29.00

0.42

314

1046

(3012441) Differential panel - Pleural fluid

602

2325

1.52

19.40

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

508

1889

1.58

19.34

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

482

1777

1.59

19.03

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

480

1769

1.59

18.99

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

169

444

2.23

18.90

1.5

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

369

1272

1.70

18.89

1.5

—

(3010503) CD19 cells [#/volume] in Blood

426

1526

1.64

18.89

2.4

2.6

0.27

0.37

e9/l

0.41

412

1489

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

522

1965

1.56

18.88

2.4

2.6

753.49

695.83

e6/l

0.97

502

1909

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

371

1282

1.70

18.83

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

170

449

2.22

18.78

1.3

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

867

3621

1.41

18.75

2.4

3.0

1696.85

531.23

u/ml

0.53

850

3575

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

136

325

2.46

18.72

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

289

933

1.82

18.48

1.9

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

289

933

1.82

18.48

1.9

2.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.86

18.39

1.6

253.10

288.96

nmol/l

0.12

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

118

266

2.60

18.25

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

619

2437

1.49

18.25

1.5

1.4

62145.43

51845.73

e6/l

0.30

359

1454

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

275

878

1.84

18.22

2.8

3.0

29.19

28.60

umol/l

0.32

213

661

(3034274) Bile acid [Moles/volume] in Serum --fasting

1108

4841

1.35

18.21

2.0

2.3

6.94

6.80

umol/l

0.05

816

3545

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

291

946

1.81

18.21

1.9

2.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

331

1119

1.74

18.17

3.1

3.4

8.17

8.20

mg/l

0.02

270

901

(3005011) Chlamydia sp Ab [Titer] in Serum

141

350

2.36

17.94

1.5

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

216

639

1.98

17.92

1.6

9.13

9.25

ug/l

0.15

216

639

(3032057) Clostridioides difficile [Presence] in Stool

163

433

2.21

17.80

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1232

5490

1.32

17.73

1.1

1.19

1.16

u/ml

0.04

543

2455

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

369

1295

1.67

17.73

1.1

1618.99

1465.99

miu/ml

1.60

369

1295

(3003129) Base excess in Capillary blood by calculation

186

523

2.09

17.67

1.8

1.7

1.11

0.13

mmol/l

2.31

172

493

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

497

1881

1.55

17.60

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

944

4045

1.37

17.58

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

228

695

1.93

17.40

2.2

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

294

973

1.77

17.38

2.1

2.8

1.16

1.18

ug/l

0.07

273

920

(3036782) Glucose [Moles/volume] in Pleural fluid

548

2127

1.51

17.32

1.3

6.42

6.24

mmol/l

0.75

508

1959

(3034988) Calcium [Moles/volume] in Capillary blood

157

416

2.21

17.26

1.6

3.3

1.17

1.19

mmol/l

1.78

151

395

(21494815) CD4 cells/100 lymphocytes in Specimen

614

2445

1.48

17.16

2.3

40.46

37.92

3.67

601

2401

(3006576) Bicarbonate [Moles/volume] in Blood

259

829

1.83

17.07

6.3

6.5

25.08

24.88

mmol/l

0.34

242

748

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

105

231

2.67

17.05

2.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

239

747

1.88

16.95

1.8

109.07

124.32

au/ml

0.20

(3045788) Cell count panel - Pleural fluid

535

2076

1.51

16.95

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

519

2011

1.52

16.56

1.3

400.13

511.15

u/l

1.16

483

1903

(3042733) HLA Ab [Presence] in Serum

277

915

1.78

16.51

5.0

4.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

581

2307

1.48

16.49

1.4

—

(3006462) Nitrate [Presence] in Urine

344

1210

1.67

16.43

3.7

2.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1434

10609

0.79

16.41

1.5

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

303

1030

1.73

16.38

2.5

2.8

137.87

138.88

au/ml

0.01

138

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

601

2408

1.47

16.32

3.8

4.9

134.65

113.48

u/ml

0.26

170

801

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6383

33552

1.13

16.21

1.5

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

551

2196

1.47

15.40

3.8

3.6

45.69

51.04

u/ml

0.33

546

2170

(3028717) Thiamine [Mass/volume] in Blood

100

227

2.58

15.35

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

105

245

2.51

15.27

1.1

—

(3015183) Erythrocyte sedimentation rate

378

1391

1.60

15.17

1.3

1.2

—

(3019174) dRVVT (LA screen)

101

232

2.55

15.16

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

133

349

2.24

15.04

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1204

5476

1.29

15.00

1.1

2.10

2.25

u/ml

0.18

631

2803

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.50

14.89

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

196

601

1.91

14.79

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

952

4215

1.33

14.43

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

125

326

2.25

14.36

1.1

1.3

32.87

43.62

mg/l

2.22

114

267

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

373

1393

1.57

14.12

1.7

1.8

1.57

2.54

u/field

2.39

273

1006

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

136

371

2.15

14.06

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

177

537

1.93

13.82

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

505

2024

1.47

13.79

1.9

2.0

1.84

2.21

u/field

0.81

240

878

(3028433) Virus identified in Specimen by Culture

250

847

1.73

13.78

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

260

892

1.71

13.71

2.5

2.3

370.26

866.92

e6/l

0.80

155

477

(40757373) Influenza virus identified in Isolate

159

466

2.00

13.68

1.8

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

103

252

2.40

13.65

1.4

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

130

354

2.15

13.52

1.5

1.4

64159.42

258426.14

nmol/l

1.03

106

291

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

481

1918

1.47

13.49

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

129

3.00

13.28

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

128

349

2.15

13.28

1.7

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

566

1.89

13.24

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1105

5056

1.29

13.21

1.4

1.5

0.39

0.43

nmol/l

0.54

834

4112

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

158

472

1.96

12.93

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

449

1783

1.48

12.88

1.4

1.3

4.45

5.58

umol/l

8.72

415

1649

(3037692) Legionella sp identified in Specimen by Organism specific culture

236

803

1.72

12.85

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1952

9556

1.20

12.66

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

387

1496

1.52

12.64

2.4

2.8

42.81

38.22

4.17

229

782

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

108

281

2.25

12.54

2.1

2.0

—

(3001729) Color of Synovial fluid

141

2.83

12.41

1.3

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

196

638

1.80

12.41

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

192

622

1.81

12.35

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.36

12.24

1.5

1.3

0.15

0.17

u/l

0.03

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

218

2.42

12.23

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

141

413

2.00

12.21

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

439

1758

1.47

12.11

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.42

12.07

1.1

1.0

548.15

360.12

u/l

0.28

(40762814) Titanium [Mass/volume] in Blood

113

305

2.17

12.06

2.3

4.01

3.64

ug/l

0.21

103

(40761995) Spermatozoa Progressive [#/volume] in Semen

937

0.41

12.04

2.6

3.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

753

3312

1.34

12.03

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

936

0.41

12.01

5.2

6.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

154

469

1.93

11.97

5.6

5.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

225

772

1.71

11.94

2.6

3.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

165

2.63

11.87

1.4

35.24

37.22

0.13

117

(3012494) Peanut IgE Ab [Units/volume] in Serum

261

934

1.64

11.85

1.1

1.99

20.17

u/ml

1.08

152

565

(3035611) Eosinophils/100 leukocytes in Synovial fluid

119

2.96

11.83

1.3

1.6

0.80

0.54

0.42

102

(43055442) Apixaban [Mass/volume] in Serum or Plasma

251

2.29

11.82

1.6

99.43

114.62

ug/l

0.73

206

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1313

6218

1.24

11.82

1.4

128.12

124.11

pmol/l

0.08

1276

6064

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

147

443

1.95

11.78

2.4

7.00

7.52

mmol/l

0.81

262

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

116

320

2.13

11.75

1.4

1.3

50.69

53.52

0.22

161

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

109

294

2.17

11.67

1.9

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

249

2.28

11.65

1.2

—

(40768806) Pleura Pathology biopsy report

561

2370

1.39

11.58

1.6

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

250

2.28

11.55

1.0

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

121

2.91

11.52

1.3

0.85

1.27

0.42

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

161

2.62

11.50

2.8

2.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

429

1731

1.46

11.42

1.5

1.7

—

(3048879) Bone marrow aspiration report

186

612

1.78

11.42

1.6

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

797

3564

1.31

11.39

2.4

2.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

169

2.57

11.36

1.7

1.8

47.87

44.01

umol/l

0.49

169

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

143

2.71

11.19

1.5

1.4

13.82

13.34

0.05

105

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

359

3073

0.68

11.10

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

400

1603

1.47

11.05

1.3

12.35

14.73

u/l

1.78

364

1490

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

138

417

1.94

11.02

1.2

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

141

2.70

11.00

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

299

1128

1.56

10.97

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

892

4071

1.29

10.97

1.4

7.02

6.97

mmol/l

0.18

799

3628

(3004775) Volume in Urine collected for unspecified duration

450

1851

1.43

10.85

2.2

2.3

700.63

672.19

0.57

303

1264

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

4.97

10.84

2.8

2.9

1.86

2.90

ug/l

1.70

(3008536) Aspergillus sp Ab [Presence] in Serum

150

471

1.87

10.71

1.8

2.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

157

501

1.84

10.67

2.5

2.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

190

643

1.73

10.65

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

153

487

1.84

10.49

1.3

1.4

67.82

88.05

mu/l

0.49

107

376

(3035880) pH of Pleural fluid

311

1201

1.52

10.32

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

157

2.54

10.26

1.1

1.0

7.88

9.21

u/l

0.28

157

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.50

10.24

1.0

1.1

0.21

g/l

0.06

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

243

889

1.60

10.19

1.8

1.7

49813.61

10993.35

u/ml

0.38

109

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

165

544

1.78

10.13

1.2

265.90

331.37

pmol/l

1.03

121

414

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

305

1178

1.52

10.12

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

301

1162

1.52

10.02

1.8

2.0

—

(3024471) HLA-A [Type]

253

940

1.58

9.97

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

128

392

1.92

9.89

3.6

2.9

14.82

14.71

ml/dl

0.15

117

361

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

103

2.90

9.83

1.2

1.3

1.81

1.44

mg/l

1.63

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

252

2.14

9.58

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

187

652

1.68

9.49

1.1

1.45

3.71

u/ml

0.74

147

574

(3024932) HLA-DR beta [Type]

247

924

1.57

9.48

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

931

4359

1.26

9.38

1.1

5.21

5.70

u/ml

0.23

397

1887

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

172

588

1.72

9.37

1.1

1.31

9.59

u/ml

3.42

117

425

(3016228) CD19 cells/100 cells in Blood

271

1039

1.53

9.35

2.1

2.0

7.97

8.93

0.72

262

1016

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

336

1352

1.46

9.19

1.0

278.56

351.90

ng/l

1.65

235

961

(3030313) Adrenal Ab [Titer] in Serum

281

2.05

9.12

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

111

334

1.95

9.06

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

337

1361

1.45

9.06

1.0

805.32

726.73

ng/l

2.24

231

930

(3009871) Measles virus Ab [Titer] in Serum

242

913

1.56

8.99

1.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

267

2.06

8.97

1.8

1.7

1.62

1.72

mg/l

0.27

222

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

337

1364

1.45

8.96

1.0

37.37

43.01

ng/l

1.37

231

952

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

504

2188

1.35

8.93

1.7

—

(40768441) Liver Pathology biopsy report

447

1907

1.38

8.84

1.6

1.4

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

108

326

1.94

8.76

1.0

0.15

0.23

u/ml

0.31

203

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

100

294

1.99

8.73

1.0

1.1

0.15

0.62

u/ml

1.52

165

(21494814) CD8 cells/100 lymphocytes in Specimen

263

1018

1.52

8.72

2.1

2.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

144

478

1.77

8.72

4.8

6.1

69.64

70.99

0.23

121

371

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

176

619

1.67

8.69

1.9

53.30

38.62

u/l

0.37

155

555

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

116

360

1.89

8.68

1.1

4.12

7.78

pmol/l

0.38

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

164

2.36

8.64

1.2

100.41

113.47

ug/l

0.32

101

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.44

8.63

1.0

1.1

2.68

2.70

0.01

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

244

934

1.53

8.53

1.1

1.0

8.38

13.24

u/ml

2.38

108

571

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

237

2.10

8.53

1.3

1.2

54.21

46.23

mg/l

0.53

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

136

447

1.78

8.52

2.6

2.5

43.77

46.16

mg/l

0.04

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

326

1.92

8.47

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

326

1.92

8.47

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

144

2.44

8.45

2.9

2.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

147

496

1.74

8.44

1.3

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

134

2.49

8.38

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

159

552

1.69

8.27

1.2

1.3

0.94

1.86

u/ml

0.86

159

543

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

107

329

1.91

8.26

2.6

3.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

118

375

1.85

8.25

4.6

4.7

52.83

44.28

ug/min

0.59

294

(40765096) Chromosome analysis panel by Banding

181

651

1.63

8.24

1.1

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.86

8.17

1.0

0.16

0.17

u/ml

0.03

(3022689) Creatine [Moles/volume] in Urine

183

662

1.62

8.15

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

977

4680

1.23

8.07

1.1

4.38

4.75

u/ml

0.24

457

2321

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

128

421

1.78

8.03

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

633

2888

1.29

7.96

1.3

1.4

8.74

7.96

mmol/l

3.93

610

2801

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

212

801

1.55

7.89

2.1

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

122

398

1.80

7.87

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

139

473

1.72

7.79

1.2

1.4

—

(3018133) Calcium [Moles/volume] in Urine

139

474

1.72

7.74

2.2

2.4

2.67

2.66

mmol/l

0.02

126

429

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

264

1.98

7.64

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

281

1.94

7.59

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

168

2.23

7.48

1.0

0.24

0.71

u/ml

1.11

152

(3023383) Lactate [Moles/volume] in Pleural fluid

176

646

1.60

7.44

1.3

3.18

3.62

mmol/l

0.96

162

585

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

122

407

1.76

7.35

1.4

1.3

69.85

317.66

ng/l

0.60

252

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

220

2.05

7.33

1.1

1.76

3.36

umol/24h

0.48

220

(40768793) Breast Pathology biopsy report

1158

5697

1.19

7.32

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

467

2070

1.32

7.31

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

790

3742

1.24

7.30

1.1

0.46

0.47

u/ml

0.03

218

993

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

140

2.35

7.30

1.2

1.1

—

(3016750) Collection duration of Urine

327

1371

1.40

7.28

2.2

507.04

500.32

min

0.53

233

1019

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

104

332

1.84

7.23

1.0

1.1

0.26

3.69

u/ml

1.12

175

(3005082) Progesterone [Moles/volume] in Serum or Plasma

265

2203

0.70

7.16

1.4

28.80

32.27

nmol/l

1.30

235

2048

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

110

361

1.79

7.02

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

111

367

1.77

6.92

2.4

2.0

—

(3013466) aPTT in Blood by Coagulation assay

159

2.21

6.89

1.1

36.53

37.26

0.24

136

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

148

531

1.63

6.89

1.3

1.6

0.21

0.22

nmol/l

0.04

109

388

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

295

1228

1.41

6.87

1.4

73.81

72.80

0.65

282

1169

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

194

2.09

6.87

1.4

1.3

9.62

13.10

pmol/l

0.81

163

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

238

1.97

6.86

3.8

4.8

2.28

2.05

mg/l

0.55

198

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

631

2937

1.26

6.84

1.9

2.0

23.46

25.51

ug/l

0.30

617

2875

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.35

6.83

1.8

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

387

1688

1.35

6.79

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

203

2.05

6.78

1.4

1.2

14.02

17.03

nmol/l

1.04

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.78

6.74

1.0

0.04

0.21

u/ml

0.83

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

101

328

1.81

6.69

1.0

1.1

0.04

0.85

u/ml

1.66

176

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

289

1205

1.41

6.68

1.4

465.10

725.31

mu/l

1.69

276

1146

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

132

2.31

6.60

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.98

6.54

1.1

1.0

4.95

5.51

mmol/l

0.33

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

144

2.24

6.52

1.1

161.68

60.27

u/l

0.42

113

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

243

1.93

6.50

1.7

1.6

1.60

1.83

mg/l

0.17

158

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

160

2.16

6.45

1.1

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

198

2.01

6.22

1.1

1.0

2.21

0.30

u/ml

0.60

128

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

277

1.84

6.17

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

118

2.33

6.14

9.9

9.8

322.09

304.40

e6/l

0.02

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.67

6.13

1.0

0.11

0.10

u/ml

0.03

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

137

498

1.61

6.12

1.4

21.72

22.94

0.19

106

407

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

101

338

1.75

6.11

1.0

1.1

0.98

3.88

u/ml

1.93

261

(3010015) Selenium [Moles/volume] in Serum or Plasma

249

1.88

6.08

2.1

2.2

1.29

1.27

umol/l

0.28

229

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

784

5536

0.83

6.05

1.3

3.03

3.82

ug/l

2.50

700

5057

(3032352) Blasts [#/volume] in Cerebral spinal fluid

280

1.82

5.98

3.4

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

106

363

1.71

5.93

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

170

2.07

5.92

1.1

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

139

513

1.59

5.86

1.5

1.3

25.39

40.44

g/l

0.70

105

399

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

2.73

1.92

mg/l

0.51

171

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

1.13

1.28

mg/l

0.12

149

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

3.18

3.67

mg/l

0.28

149

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

2.39

1.84

mg/l

0.41

153

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

1.62

1.78

mg/l

0.16

170

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

0.95

0.96

mg/l

0.02

161

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

2.71

2.77

mg/l

0.03

171

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

2.01

2.10

mg/l

0.05

158

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

240

1.88

5.85

1.7

1.6

2.61

3.00

mg/l

0.24

162

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

112

392

1.68

5.81

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

164

2.07

5.76

1.2

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

195

779

1.47

5.74

1.4

57.74

62.16

0.83

142

645

(3026692) Albumin [Mass/volume] in Peritoneal fluid

153

582

1.54

5.68

1.5

1.4

13.52

13.51

g/l

0.00

116

444

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

226

1.89

5.67

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

222

1.90

5.66

1.3

1.20

1.74

ml/s/173m2

0.77

143

(3011841) English Walnut IgE Ab [Units/volume] in Serum

338

1.72

5.62

1.0

1.1

0.48

5.00

u/ml

2.29

267

(3010370) Gastrin [Moles/volume] in Serum or Plasma

112

396

1.66

5.61

1.5

1.8

50.85

43.43

pmol/l

0.35

337

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

219

1.90

5.58

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

215

1.91

5.57

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

135

502

1.58

5.54

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

258

1.82

5.50

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

140

2.14

5.47

1.2

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

193

1.94

5.38

1.0

1.15

1.98

u/ml

0.27

152

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.67

5.33

1.0

0.20

0.26

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

224

934

1.41

5.29

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

300

1315

1.34

5.22

1.8

2.3

194.77

204.57

u/l

1.58

300

1303

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

891

0.61

5.20

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2108

11116

1.12

5.17

1.8

1.6

3.99

3.83

mg/l

0.31

1687

7676

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

135

511

1.55

5.17

1.2

—

(3033799) Differential panel - Peritoneal fluid

179

720

1.46

5.14

2.5

1.8

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

3.45

5.14

1.1

1.0

0.09

0.30

u/ml

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

176

1.97

5.13

2.0

161.57

171.45

ug/g

0.22

152

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

125

2.16

5.08

3.7

3.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

257

1.78

5.04

1.3

663.30

191.10

u/l

0.44

187

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

161

2.00

5.04

1.1

1.24

1.15

u/field

0.22

110

(3042951) Complement C1q Ab [Units/volume] in Serum

114

2.21

5.04

1.3

1.2

16.18

20.76

u/ml

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.83

5.01

1.4

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

110

401

1.61

4.95

2.8

2.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

147

2.03

4.88

1.0

46.08

0.65

u/ml

0.47

(3041918) Cholesterol [Moles/volume] in Pleural fluid

107

390

1.61

4.83

1.3

1.2

1.64

1.68

mmol/l

0.10

238

(3001893) Eosinophils/100 leukocytes in Pleural fluid

167

672

1.46

4.82

1.4

2.66

2.99

0.16

124

576

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1891

9966

1.12

4.72

1.4

—

(3012898) Urea [Moles/volume] in Urine

254

1.75

4.72

1.5

1.7

149.03

179.37

mmol/l

1.53

222

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

186

1.89

4.71

1.1

26.06

16.45

iu/ml

0.29

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

224

1.81

4.71

1.1

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

357

1.63

4.67

2.7

2.5

0.94

1.57

mmol/l

2.85

261

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

4.66

11.6

8.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

146

2.01

4.64

1.0

1.1

—

(3014891) Appearance of Pleural fluid

309

1.67

4.60

1.4

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

200

840

1.40

4.60

1.9

1.8

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.81

4.55

1.0

0.06

0.10

u/ml

0.18

(40768795) Lymph node Pathology biopsy report

531

2548

1.22

4.54

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

172

1.91

4.53

3.9

4.9

—

(3025130) Human papilloma virus identified in Specimen

858

4321

1.17

4.31

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

264

1173

1.32

4.28

3.3

—

(3042628) Porphyrins [Moles/volume] in Urine

8.79

4.19

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

124

2.03

4.16

1.5

2.0

0.67

0.66

umol/l

0.05

(3000919) Neutrophils/100 leukocytes in Pleural fluid

147

598

1.44

4.08

1.4

1.3

23.84

20.82

0.59

125

544

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

344

1.58

4.03

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

285

1.65

4.02

1.3

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

1.87

4.01

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

197

1.79

4.01

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

210

1.76

4.01

1.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

401

1897

1.24

3.98

1.3

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

346

1611

1.26

3.95

1.4

5.63

5.51

mmol/l

1.23

327

1527

(3007700) Barley IgE Ab [Units/volume] in Serum

131

1.97

3.93

1.0

42.35

0.71

u/ml

0.47

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

229

1.72

3.92

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.69

3.89

10.2

8.5

42.50

45.64

0.17

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

100

2.11

3.86

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

368

1.55

3.80

1.6

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

142

584

1.43

3.76

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

228

1.70

3.74

1.1

1.0

0.67

0.99

u/ml

0.46

146

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

323

1.58

3.74

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

141

580

1.43

3.73

1.2

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

5.86

3.71

1.0

19.90

23.30

umol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

310

1.59

3.70

1.4

1.2

0.96

1.15

mmol/l

0.14

200

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

141

581

1.42

3.70

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

335

1569

1.25

3.68

5.9

6.8

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

186

1.76

3.64

1.0

1.1

19.62

17.85

u/ml

0.10

155

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

262

1.63

3.61

2.9

2.8

1.38

1.25

mg/l

0.13

178

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

140

1.88

3.59

1.1

2.21

3.22

u/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

140

580

1.42

3.58

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1104

5742

1.13

3.57

4.3

3.1

24.01

27.40

mg/l

2.48

691

3651

(3020874) Milk IgE Ab [Units/volume] in Serum

425

2051

1.22

3.55

1.1

2.77

2.44

u/ml

0.08

174

708

(3027570) Oxalate [Moles/time] in 24 hour Urine

179

1.77

3.54

1.8

1.3

359.72

306.82

umol/24h

0.88

179

(3023487) Leukocytes [#/volume] in Peritoneal fluid

194

850

1.34

3.54

2.7

1.8

1242.48

3835.74

e6/l

1.07

129

582

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

104

2.03

3.52

1.1

1.4

1.06

1.17

u/field

0.28

(3024316) Viscosity of Plasma

117

1.95

3.46

2.2

1.7

1.55

1.63

mpas

0.30

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.11

3.45

1.1

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

172

1.77

3.45

1.1

0.45

2.52

u/ml

2.23

122

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

143

600

1.40

3.43

11.9

7.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

122

1.92

3.39

1.5

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

173

1.76

3.39

1.1

1.2

29.63

23.76

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

127

523

1.42

3.38

12.5

7.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

332

1.54

3.37

1.4

15.62

10.92

0.71

182

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.06

3.36

1.3

1.2

0.07

g/l

0.06

(3027974) Hepatitis B virus e Ag [Presence] in Serum

174

1.75

3.33

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

324

1.54

3.31

2.9

3.3

40.41

42.50

umol/l

0.32

287

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.09

3.28

1.0

1.1

156.42

270.58

pmol/l

1.49

(3010937) Rubella virus Ab [Presence] in Serum

188

1.71

3.28

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.04

3.28

1.8

2.7

4.27

4.37

mmol/l

0.46

(3011544) Albumin [Mass/volume] in Pleural fluid

207

1.67

3.22

1.1

17.52

17.20

g/l

0.11

193

(3041672) Baker's yeast Ab [Presence] in Serum

150

1.80

3.21

1.0

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

163

1.76

3.21

1.5

1.3

16.41

18.91

pmol/l

0.45

134

(3042301) Urate [Moles/volume] in Synovial fluid

2.77

3.20

1.1

1.0

345.18

333.26

umol/l

0.12

(3032743) Legionella sp IgG Ab [Presence] in Serum

168

1.74

3.17

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

223

1665

0.78

3.14

1.8

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

130

1.85

3.13

1.1

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.32

3.12

1.0

0.05

0.28

u/ml

0.60

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

209

1.65

3.12

1.0

1.1

7.04

9.83

u/ml

0.39

145

(3019768) Coxiella burnetii Ab [Presence] in Serum

152

1.77

3.09

1.3

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

4.03

3.07

2.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

170

1.72

3.06

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

106

1.94

3.06

1.1

0.94

1.26

u/field

0.54

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.18

3.06

3.9

3.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

179

1.70

3.05

1.8

3.1

4.71

470.11

pmol/l

0.67

(3033942) Copper [Moles/time] in 24 hour Urine

127

1.85

3.05

1.1

1.3

0.23

1.00

umol/24h

1.81

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.17

3.03

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

203

1523

0.78

3.00

1.2

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

176

1.70

2.98

1.0

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.15

2.97

1.0

0.36

0.99

u/ml

0.87

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

254

1.57

2.93

1.4

71.57

72.85

0.11

210

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.15

2.89

1.1

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

201

915

1.29

2.88

1.3

1.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.42

2.82

1.5

1.4

0.70

0.59

u/field

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.93

2.81

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.16

2.80

9.3

7.6

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

211

1.61

2.80

1.4

1.34

9.25

u/ml

1.60

176

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

4.40

2.78

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

401

1.43

2.78

1.0

81.00

81.39

ug/l

0.03

325

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

102

1.90

2.75

1.2

1.5

467.67

506.68

nmol/l

0.14

102

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.45

2.75

2.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

119

1.82

2.75

1.1

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.09

2.71

1.2

1.1

—

mmol/l

—

(3044007) Cell count panel - Peritoneal fluid

153

679

1.32

2.67

2.6

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

165

1249

0.77

2.67

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

178

1.65

2.64

5.5

5.4

—

(40762887) Creatinine [Moles/volume] in Blood

2.40

2.63

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

398

1.41

2.56

2.1

1.9

—

(3017400) Magnesium [Moles/volume] in Urine

2.20

2.56

1.0

1.3

2.40

3.44

mmol/l

1.11

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

311

1.47

2.55

2.3

2.5

0.59

0.57

u/field

0.06

311

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

168

761

1.29

2.55

2.6

1.7

5933.94

12515.75

e6/l

0.98

415

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

307

1490

1.21

2.54

1.2

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

202

937

1.26

2.54

1.2

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

190

1.60

2.51

2.9

2.4

22.05

20.55

mmol/l

0.17

166

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

273

1315

1.22

2.46

1.2

1.3

—

(4212803) Bone marrow aspirate examination

210

1.56

2.44

1.1

—

(36303858) Crystals [Presence] in Urine

2.51

2.41

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

763

3989

1.12

2.40

3.9

3.6

31.09

40.57

u/ml

0.86

733

3852

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.98

2.38

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

746

4892

0.89

2.38

1.6

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.07

2.38

4.4

4.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

336

1.43

2.36

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.09

2.29

5.4

5.5

2.62

6.47

mg/l

2.10

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.63

2.28

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.63

2.28

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.63

2.28

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.63

2.28

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.63

2.28

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.63

2.28

1.0

—

(3045177) Copper [Moles/volume] in Urine

2.34

2.26

1.0

1.1

0.15

0.56

umol/l

—

(3001556) Androgen free Index in Serum or Plasma

365

1.40

2.22

1.2

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

136

613

1.30

2.19

1.3

1.2

260.71

308.45

ug/l

0.09

321

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

203

1.53

2.14

1.1

23.53

20.88

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

203

1.53

2.14

1.1

24.06

32.27

u/ml

0.32

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.95

2.14

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

6476

39255

0.96

2.13

1.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.60

2.08

1.0

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

122

1.68

2.06

1.6

1.8

197.86

201.61

ng/l

0.08

106

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.35

2.02

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.35

2.02

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

110

488

1.32

2.02

1.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

4.40

2.00

1.3

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

106

1.71

1.97

1.5

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

374

1.36

1.96

1.3

1.4

—

(40759632) Porphyrins [Mass/mass] in Stool

2.51

1.96

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

120

1.66

1.93

3.9

—

(3000285) Sodium [Moles/volume] in Blood

291

1.41

1.93

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

200

1.49

1.89

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

186

1.51

1.88

1.4

1.3

—

11.83

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.20

1.88

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

210

1.48

1.88

2.6

2.2

64.61

55.40

0.88

136

(3014599) Egg white IgE Ab [Units/volume] in Serum

394

2015

1.15

1.84

1.1

2.73

5.74

u/ml

0.83

131

565

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

235

1.45

1.84

1.2

1.1

24.33

20.33

u/l

0.54

151

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

145

1.58

1.83

4.9

5.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

374

1.35

1.83

7.2

7.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

339

1.37

1.83

12.0

9.6

0.33

0.42

umol/l

0.65

313

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

276

1377

1.18

1.80

4.9

6.6

491.03

3492.08

u/ml

0.83

319

(3006567) Chloride [Moles/time] in 24 hour Urine

2.08

1.78

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.95

1.71

2.1

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

4.19

1.67

1.2

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

4.19

1.67

1.2

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.39

1.65

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

126

1.58

1.65

4.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

140

1.55

1.64

1.4

1.8

—

(36304079) Mucus [Presence] in Urine sediment

2.93

1.60

1.0

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.88

1.57

1.0

1.1

0.46

0.05

g/l

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

122

571

1.25

1.56

1.3

1.6

4.91

5.70

nmol/l

1.47

114

546

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

147

0.52

1.56

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.92

1.55

2.1

1.3

1.94

2.28

mmol/24h

0.49

(3004446) Plasmodium sp identified in Blood by Light microscopy

336

1.33

1.51

2.4

2.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

326

1.33

1.50

3.0

3.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

251

1.38

1.49

1.0

0.60

1.58

u/ml

0.91

172

(3046861) Legionella sp Ag [Presence] in Urine

130

1.53

1.47

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

278

1.35

1.44

1.3

29.99

24.57

0.50

226

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.82

1.43

1.1

1.0

3.11

0.60

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

938

5103

1.08

1.43

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

938

5104

1.08

1.43

1.1

—

(3006598) pH of Arterial cord blood

286

0.68

1.41

1.1

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.91

1.38

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.26

1.38

1.0

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

177

1.42

1.33

2.5

2.3

—

(3004959) Base excess in Arterial cord blood by calculation

282

0.69

1.33

1.1

1.0

-2.00

-2.20

mmol/l

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

335

1.29

2.9

3.2

22.37

22.90

mg/l

0.14

317

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.78

1.28

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

130

1.49

1.28

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

1.71

1.27

1.4

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

2.93

1.25

1.2

1.0

0.00

u/l

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

2.08

1.25

1.0

1.2

78.91

80.58

0.12

(3032868) Hemoglobin electrophoresis panel in Blood

280

1.32

1.25

1.7

1.6

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.73

1.25

1.4

98.33

134.37

nmol/l

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

226

1150

1.15

1.25

2.5

2.4

140.93

152.75

nmol/l

0.95

194

998

(42870560) Thyrotropin [Units/volume] in Cord blood

319

0.72

1.24

1.0

6.38

9.05

mu/l

4.15

263

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

117

1.50

1.23

1.1

1.0

8.79

9.07

0.22

104

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

117

1.50

1.23

1.1

1.0

36.14

35.55

0.33

106

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.86

1.22

1.0

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.77

1.20

1.3

1.4

40.30

60.26

e6/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

340

1.28

1.17

1.3

2.0

6.86

7.53

mmol/l

0.67

121

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

130

639

1.19

1.12

1.1

55.39

63.73

u/ml

0.67

125

626

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.53

1.11

1.0

0.11

0.19

u/ml

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.57

1.11

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

349

1.26

1.09

2.7

52.17

74.13

pmol/l

1.21

300

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.55

1.09

1.1

248.29

262.58

nmol/l

0.16

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.53

1.08

1.0

0.14

0.43

u/ml

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

358

2315

0.91

1.06

20.1

18.7

1455.89

2796.29

nmol/l

0.96

342

2226

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.66

1.05

1.0

—

1.01

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

127

1.43

1.03

28.1

8.6

—

(40768800) Prostate Pathology biopsy report

848

4665

1.07

1.03

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.95

1.03

1.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

238

1.31

1.03

3.3

3.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.75

1.02

1.1

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.90

1.02

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

276

1447

1.12

1.02

1.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.77

1.00

1.5

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.69

0.99

1.0

1.1

0.03

0.07

g/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

158

1.37

0.99

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

196

1008

1.14

0.99

1.2

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.34

0.96

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

343

1829

1.10

0.94

1.1

1.0

0.60

1.01

u/ml

0.55

106

491

(3051101) Glucose [Moles/volume] in Cord blood

432

1.21

0.92

4.6

5.8

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.62

0.92

1.4

1.7

109.75

120.38

ug/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.50

0.90

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

230

1205

1.12

0.89

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

391

0.79

0.88

1.2

21.37

20.29

mmol/l

0.93

334

(3029396) Erythrocyte agglutination [Presence] in Blood

175

1159

0.88

0.85

3.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.80

0.84

1.0

—

(3003577) Lead [Moles/volume] in Blood

217

1.27

0.79

1.4

0.10

0.25

umol/l

3.79

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.78

0.79

1.1

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

110

1.39

0.77

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

171

1.30

0.77

2.7

2.1

13.67

18.15

0.34

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.25

0.77

1.0

1.1

19.00

17.23

umol/l

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

345

2192

0.92

0.77

14.7

13.3

796.40

1528.91

nmol/l

0.81

333

2122

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.62

0.77

1.1

—

(1761868) Lipid panel - Serum or Plasma

17617

104202

0.99

0.77

2.9

2.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

428

2331

1.08

0.77

1.3

170.13

189.85

pmol/l

0.37

428

2331

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.58

0.75

1.0

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.45

0.75

1.0

3.90

0.32

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

131

1.34

0.75

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.09

0.74

1.2

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.09

0.74

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.09

0.74

1.2

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.09

0.74

1.2

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.65

0.74

2.0

2.7

—

(40760512) CD34 cells/100 cells in Bone marrow

1.78

0.72

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

348

1.20

0.72

8.0

6.2

—

(3007147) Virus identified in Stool by Electron microscopy

1.95

0.70

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.71

0.69

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

108

1.36

0.68

1.7

2.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.41

0.68

4.5

6.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.62

0.62

1.1

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.61

0.0

4.0

—

139.50

—

(3009992) Blasts/100 cells in Bone marrow

1.85

0.60

2.5

1.5

4.17

21.74

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.85

0.60

1.2

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.51

0.58

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.46

0.58

1.8

2.7

3.63

2.37

mu/l

0.33

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

341

2133

0.94

0.56

1.6

1.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.34

0.51

1.2

1506.33

4376.19

ng/l

1.17

(3044336) Cobalt [Moles/volume] in Urine

0.64

0.50

3.4

2.4

22.54

25.43

nmol/l

—

(3020650) Glucose [Presence] in Urine

149

795

1.10

0.50

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

147

1.24

0.48

1.1

1.4

—

(3013862) HLA-DP [Type]

105

1.28

0.47

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

126

1.26

0.47

4.0

2.2

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.35

0.47

1.8

2.4

0.28

0.39

ug/l

0.19

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.35

0.47

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.50

0.47

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.46

0.46

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

360

0.86

0.46

8.1

7.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.72

0.45

1.2

1.1

24.40

31.98

nmol/24h

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.64

0.44

1.2

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.35

0.43

1.1

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.43

0.0

1.8

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

6.6

—

(4281824) Cell count and differential, peritoneal fluid

505

2836

1.04

0.41

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

254

1.15

0.40

1.0

—

(3022475) Manganese [Moles/volume] in Blood

173

1.19

0.39

1.3

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.30

0.38

1.1

—

(40760409) HLA-A [Type] by High resolution

104

1.24

0.37

1.0

—

(40760410) HLA-B [Type] by High resolution

104

1.24

0.37

1.0

—

(40763590) HLA-DQ beta [Type]

104

1.24

0.37

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

262

1.14

0.36

6.3

2.5

18.65

7.70

2.59

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.28

0.36

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2798

16650

0.98

0.35

1.7

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

308

1893

0.95

0.34

1.1

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.35

0.34

1.0

—

(40758358) Immune stain study

118

0.79

0.34

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

106

1.22

0.32

1.2

1.36

1.41

0.26

106

(46236302) HLA-C [Type] by High resolution typing

106

1.22

0.32

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

218

0.86

0.32

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

116

0.81

0.30

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

480

1.09

0.29

1.9

1.8

2.57

2.81

ug/l

0.10

298

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.30

0.28

2.8

2.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.33

0.28

3.9

3.8

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.24

0.26

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.26

0.26

1.6

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.21

0.25

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.40

0.24

1.4

1.1

—

(3032641) Amino acids panel - Urine

1.26

0.22

1.1

1.3

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

10.8

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.2

—

2.57

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.1

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.22

0.0

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

154

0.88

0.21

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

129

1.14

0.19

3.2

3.5

—

0.00

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.14

0.17

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.14

0.17

1.3

—

(3035060) Mercury [Moles/volume] in Blood

1.20

0.17

1.3

1.6

9.43

9.94

nmol/l

—

(3008607) Semen analysis panel

254

0.92

0.16

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

526

3141

0.98

0.15

1.6

7.96

7.58

mmol/l

3.32

504

3012

(3045462) Protein/Creatinine [Ratio] in Urine

361

0.94

0.14

7.2

5.4

80.06

204.01

g/mol

0.44

335

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

178

1.09

0.13

1.0

—

(3022670) pH of Venous cord blood

100

0.88

0.13

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.82

0.13

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

255

0.94

0.10

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

720

4260

0.99

0.08

3.1

2.3

13.18

13.11

1.12

711

4206

(3013762) Body weight Measured

121

0.92

0.08

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.11

0.08

1.1

1012.86

2108.11

titre

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.08

0.08

1.9

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

115

691

0.98

0.07

1.6

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

1.08

0.07

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

1.05

0.06

1.1

—

(3049233) Organic acids panel - Urine

1.09

0.06

1.1

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.09

0.04

5.5

5.1

0.40

0.22

mmol/l

0.77

(3034614) HLA Ag [Interpretation]

1.01

0.00

1.1

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

1.02

0.00

6.2

6.9

—

(3009677) Dengue virus Ab [Presence] in Serum

127

1.02

0.00

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

121

707

1.00

0.00

2.4

88.91

112.17

ng/l

1.14

411

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.98

-0.00

1.0

1.2

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SOFTTISSUEOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SOFTTISSUEOTH	1.372 [1.25, 1.51]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.105

During the follow-up period (1.1.1998 — 31.12.2019), 30860 out of 221248 females with M13_SOFTTISSUEOTH died.

Males

Parameter	HR [95% CI]	p-value
M13_SOFTTISSUEOTH	1.459 [1.31, 1.62]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 22071 out of 138048 males with M13_SOFTTISSUEOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_SOFTTISSUEOTH.

N-year risk	Females	Males
1	0.066%	0.294%
5	0.629%	1.704%
10	1.598%	3.968%
15	3.116%	7.587%
20	5.77%	12.373%

Relationships between endpoints

↥

Index endpoint: M13_SOFTTISSUEOTH – Other soft tissue disorders, not elsewhere classified

GWS hits: 18

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other soft tissue disorders, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints